Beckman Coulter, Inc. v. Cytek Biosciences, Inc.
1:24-cv-00945
Overview
Case Number
1:24-cv-00945
Filing Date
2024-08-14
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Cytek Biosciences, Inc.
Represented By
7 Attorneys ListedMorris, Nichols, Arsht & Tunnell
Tel: (302) 333-8052
1201 North Market St., P.O. Box 1347, Wilmington, DE 19899
Cooley LLP
Tel: (312) 881-6383
Fax: (312) 881-6598
30 S. 9th St., 7th Floor, Minneapolis, MN 55402
Morris, Nichols, Arsht & Tunnell
Tel: (302) 351-9106
1201 North Market St., P.O. Box 1347, Wilmington, DE 19899
Morris, Nichols, Arsht & Tunnell
Tel: (302) 658-9200
1201 North Market St., P.O. Box 1347, Wilmington, DE 19899
Plaintiff
Beckman Coulter, Inc.
Represented By
12 Attorneys ListedRichards, Layton & Finger, PA
Tel: (302) 651-7508
920 North King St., Wilmington, DE 19801
Richards, Layton & Finger, P.A.
Tel: (302) 651-7818
920 North King St., Wilmington, DE 19801
Counter Claimant
Cytek Biosciences, Inc.
Represented By
7 Attorneys ListedMorris, Nichols, Arsht & Tunnell
Tel: (302) 333-8052
1201 North Market St., P.O. Box 1347, Wilmington, DE 19899
Cooley LLP
Tel: (312) 881-6383
Fax: (312) 881-6598
30 S. 9th St., 7th Floor, Minneapolis, MN 55402
Morris, Nichols, Arsht & Tunnell
Tel: (302) 351-9106
1201 North Market St., P.O. Box 1347, Wilmington, DE 19899
Morris, Nichols, Arsht & Tunnell
Tel: (302) 658-9200
1201 North Market St., P.O. Box 1347, Wilmington, DE 19899
Counter Defendant
Beckman Coulter, Inc.
Represented By
12 Attorneys ListedRichards, Layton & Finger, PA
Tel: (302) 651-7508
920 North King St., Wilmington, DE 19801
Richards, Layton & Finger, P.A.
Tel: (302) 651-7818
920 North King St., Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Colm Felix Connolly
Patents Involved
There are 4 patents involved in this case.
| Application Number | Patent Number | External Links |
|---|---|---|
| - | US10330582 | |
| - | US11703443 | |
| - | US12174107 | |
| - | US12174106 |
Docket Entries
COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Cytek Biosciences, Inc. ( Filing fee $ 405, receipt number ADEDC-4476161.) - filed by Beckman Coulter, Inc. (Attachments: # 1 Exhibit 1-6, # 2 Exhibit 7-12, # 3 Exhibit 13-17, # 4 Exhibit 18-21, # 5 Civil Cover Sheet)(cdd). (Entered: 08/15/2024)
2024-08-14
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) (Entered: 08/15/2024)
2024-08-14
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,330,582; 11,703,443. (cdd) (Entered: 08/15/2024)
2024-08-14
1
Summons Issued as to Cytek Biosciences, Inc. on 8/14/2024. (cdd) (Entered: 08/15/2024)
2024-08-14
1
DEFICIENCY NOTICE issued by the Court to Plaintiff: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (cdd)
2024-08-14
1
No Actions
Deficiency Notice - No 7.1 Statement Filed
2024-08-15
1
No Actions
SUMMONS Returned Executed by Beckman Coulter, Inc..Cytek Biosciences, Inc. served on 8/15/2024, answer due 9/5/2024. (Haynes, Christine) (Entered: 08/16/2024)
2024-08-16
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Danaher Corporation for Beckman Coulter, Inc. filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 08/16/2024)
2024-08-16
1
STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 08/21/2024)
2024-08-21
1
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
2024-08-21
1
No Actions
Case Assigned/Reassigned
2024-08-21
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Omar A. Khan, Jeffrey Dennhardt, Lauren Matlock-Colangelo, and Asher S. McGuffin - filed by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 09/03/2024)
2024-09-03
1
Pro Hac Vice Fee - Credit Card Payment received for Omar A. Khan, Jeffrey Dennhardt, Lauren Matlock-Colangelo, and Asher S. McGuffin. ( re 8 MOTION for Pro Hac Vice Appearance of Attorney Omar A. Khan, Jeffrey Dennhardt, Lauren Matlock-Colangelo, and Asher S. McGuffin )( Payment of $ 200, receipt number ADEDC-4489955).(Cottrell, Frederick) (Entered: 09/03/2024)
2024-09-03
1
-District Court Pro Hac Vice Fee - 04 Attorneys Credit Card Payment
2024-09-03
1
No Actions
Unopposed MOTION for Extension of Time to File Answer - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 09/04/2024)
2024-09-04
1
SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Omar A. Khan, Jeffrey Dennhardt, Lauren Matlock-Colangelo, and Asher S. McGuffin, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 9/4/2024. (kmd)
2024-09-04
1
No Actions
SO ORDERED
2024-09-04
1
No Actions
SO ORDERED, re 10 Unopposed MOTION for Extension of Time to File Answer filed by Beckman Coulter, Inc. Reset Answer Deadlines: Cytek Biosciences, Inc. answer due 10/7/2024. Ordered by Judge Colm F. Connolly on 9/5/2024. (kmd)
2024-09-05
1
No Actions
SO ORDERED AND ~Util - Set/Reset Answer Deadline
2024-09-05
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Reuben Chen and Adam Pivovar - filed by Cytek Biosciences, Inc.. (Jacobs, Karen) (Entered: 10/04/2024)
2024-10-04
1
Pro Hac Vice Fee - Credit Card Payment received for Reuben Chen and Adam Pivovar. ( re 11 MOTION for Pro Hac Vice Appearance of Attorney Reuben Chen and Adam Pivovar )( Payment of $ 100, receipt number ADEDC-4516233).(Jacobs, Karen) (Entered: 10/04/2024)
2024-10-04
1
NOTICE of Appearance of Elizabeth M. Flanagan by Cytek Biosciences, Inc. (Jacobs, Karen) (Entered: 10/04/2024)
2024-10-04
1
Attorney Elizabeth M. Flanagan for Cytek Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
2024-10-04
1
No Actions
SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Reuben Chen and Adam Pivovar, filed by Cytek Biosciences, Inc. Ordered by Judge Colm F. Connolly on 10/4/2024. (kmd)
2024-10-04
1
No Actions
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
2024-10-04
1
No Actions
SO ORDERED
2024-10-04
1
No Actions
Add Attorneys - PHV only
2024-10-04
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Dustin Knight, Rosalynd Upton, and David Yun - filed by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 10/07/2024)
2024-10-07
1
Pro Hac Vice Fee - Credit Card Payment received for Dustin Knight, Rosalynd Upton, and David Yun. ( re 14 MOTION for Pro Hac Vice Appearance of Attorney Dustin Knight, Rosalynd Upton, and David Yun )( Payment of $ 150, receipt number ADEDC-4517358).(Clark, Cameron) (Entered: 10/07/2024)
2024-10-07
1
ANSWER to 1 Complaint, with Jury Demand, COUNTERCLAIM against Beckman Coulter, Inc. by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 10/07/2024)
2024-10-07
1
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cytek Biosciences, Inc.. (Jacobs, Karen) (Entered: 10/07/2024)
2024-10-07
1
SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Dustin Knight, Rosalynd Upton, and David Yun, filed by Cytek Biosciences, Inc. Ordered by Judge Colm F. Connolly on 10/7/2024. (kmd)
2024-10-07
1
No Actions
-District Court Pro Hac Vice Fee - 03 Attorneys Credit Card Payment
2024-10-07
1
No Actions
SO ORDERED
2024-10-07
1
No Actions
Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 11/6/2024 at 01:00 PM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 10/16/2024. (mws) (Entered: 10/17/2024)
2024-10-17
1
Pro Hac Vice Attorney Asher S. McGuffin for Beckman Coulter, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)
2024-10-18
1
No Actions
Pro Hac Vice Attorney Jeffrey A. Dennhardt for Beckman Coulter, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)
2024-10-18
1
No Actions
Pro Hac Vice Attorney Omar A. Khan for Beckman Coulter, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)
2024-10-18
1
No Actions
Add Attorneys - PHV only
2024-10-18
1
No Actions
Pro Hac Vice Attorney Lauren Matlock-Colangelo for Beckman Coulter, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)
2024-10-21
1
No Actions
Add Attorneys - PHV only
2024-10-21
1
No Actions
ANSWER to 16 Answer to Complaint, Counterclaim, COUNTERCLAIM against All Defendants by Beckman Coulter, Inc..(Cottrell, Frederick) (Entered: 10/28/2024)
2024-10-28
1
NOTICE OF SERVICE of Plaintiff's First Set of Requests for Production of Documents and Things to Defendant Cytek Biosciences, Inc. (Nos. 1-150) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 10/29/2024)
2024-10-29
1
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding [Proposed] Scheduling Order - re 18 Order Setting Scheduling Conference,. (Attachments: # 1 [Proposed] Scheduling Order)(Cottrell, Frederick) (Entered: 11/04/2024)
2024-11-04
1
ORAL ORDER: A 5-day Jury Trial is set to begin on 8/17/2026 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Parties shall submit no later than 11/13/2024 a revised proposed scheduling order. Ordered by Judge Colm F. Connolly on 11/6/2024. (mws) (Entered: 11/06/2024)
2024-11-06
1
Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Teleconference held on 11/6/2024. (Court Reporter Bonnie Archer.) (mws)
2024-11-06
1
No Actions
Scheduling Conference
2024-11-06
1
No Actions
Oral Order AND ~Util - Set Scheduling Order Deadlines
2024-11-06
1
No Actions
Official Transcript of Scheduling Teleconference held on 11/6/2024 before Judge Colm F. Connolly. Court Reporter/Transcriber Bonnie Archer. Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/3/2024. Redacted Transcript Deadline set for 12/13/2024. Release of Transcript Restriction set for 2/10/2025. (mws) (Entered: 11/12/2024)
2024-11-12
1
Joint PROPOSED ORDER [Scheduling Order] by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 11/13/2024)
2024-11-13
1
SCHEDULING ORDER: Joinder of Parties due by 6/11/2025. Amended Pleadings due by 6/11/2025. Fact Discovery completed by 9/26/2025. Expert Discovery due by 1/30/2026. Dispositive Motions due by 3/6/2026. Joint Claim Construction Brief due by 6/13/2025. A Markman Hearing is set for 7/16/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 7/17/2026. A Final Pretrial Conference is set for 8/7/2026 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Jury Trial is set for 8/17/2026 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. A Jury Trial is set for 8/18/2026 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 11/14/2024. (mws) (Entered: 11/14/2024)
2024-11-14
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s First Set of Interrogatories to Plaintiff Beckman Coulter, Inc. (Nos. 1-12) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 11/14/2024)
2024-11-14
1
NOTICE OF SERVICE of Plaintiff's First Set of Interrogatories to Defendant Cytek Biosciences, Inc. (Nos. 1-15) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 11/15/2024)
2024-11-15
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s First Set of Requests for Production to Plaintiff Beckman Coulter, Inc. (Nos. 1-48) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 11/15/2024)
2024-11-15
1
STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to December 4, 2024 - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 11/20/2024)
2024-11-20
1
SO ORDERED, re 29 STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to December 4, 2024, filed by Cytek Biosciences, Inc. Signed by Judge Colm F. Connolly on 11/21/2024. (kmd) (Entered: 11/21/2024)
2024-11-21
1
NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiff's First Set of Requests for Production of Documents and Things (Nos. 1-150) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 12/03/2024)
2024-12-03
1
STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to December 11, 2024 - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 12/04/2024)
2024-12-04
1
SO ORDERED, re 32 STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to December 11, 2024, filed by Cytek Biosciences, Inc. Ordered by Judge Colm F. Connolly on 12/5/2024. (kmd)
2024-12-05
1
No Actions
SO ORDERED
2024-12-05
1
No Actions
NOTICE OF SERVICE of (1) Defendant Cytek Biosciences, Inc.'s Rule 26(a)(1) Initial Disclosures; and (2) Cytek's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 12/06/2024)
2024-12-06
1
NOTICE OF SERVICE of (1) Plaintiff's Disclosures Under Paragraph 3 of the Delaware Default Standard for Discovery and Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiff's Paragraph 4(a) Disclosures Under the Default Standard for Discovery filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 12/06/2024)
2024-12-06
1
STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to December 20, 2024 - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 12/11/2024)
2024-12-11
1
SO ORDERED, re 35 STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to December 20, 2024, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 12/12/2024. (kmd)
2024-12-12
1
No Actions
SO ORDERED
2024-12-12
1
No Actions
NOTICE OF SERVICE of Plaintiff's Objections & Responses to Defendant's First Set of Interrogatories (Nos. 1-12) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 12/13/2024)
2024-12-13
1
NOTICE OF SERVICE of Plaintiff's Objections & Responses to Defendant's First Set of Requests for Production (Nos. 1-48) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 12/16/2024)
2024-12-16
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 1-15) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 12/16/2024)
2024-12-16
1
Proposed STIPULATION for Protective Order by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 12/20/2024)
2024-12-20
1
STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 12/23/2024. (kmd) (Entered: 12/23/2024)
2024-12-23
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Core Technical Document Production filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 01/09/2025)
2025-01-09
1
First AMENDED COMPLAINT against Cytek Biosciences, Inc.- filed by Beckman Coulter, Inc.. (Attachments: # 1 Patent/Trademark Report, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Cottrell, Frederick) (Entered: 01/09/2025)
2025-01-09
1
EXHIBIT re 42 Amended Complaint, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 7, # 2 Exhibit 8, # 3 Exhibit 9, # 4 Exhibit 10, # 5 Exhibit 11, # 6 Exhibit 12, # 7 Exhibit 13, # 8 Exhibit 14, # 9 Exhibit 15, # 10 Exhibit 16, # 11 Exhibit 17, # 12 Exhibit 18, # 13 Exhibit 19, # 14 Exhibit 20, # 15 Exhibit 21, # 16 Exhibit 22, # 17 Exhibit 23, # 18 Exhibit 24, # 19 Exhibit 25)(Cottrell, Frederick) (Entered: 01/09/2025)
2025-01-09
1
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding the First Amended Complaint - re 25 Scheduling Order,,,. (Cottrell, Frederick) (Entered: 01/09/2025)
2025-01-09
1
NOTICE OF SERVICE of (1) First Amended Disclosures Under Paragraph 3 of the Delaware Default Standard for Discovery and Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) First Amended Paragraph 4(a) Disclosures Under the Default Standard for Discovery filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 01/09/2025)
2025-01-09
1
STIPULATION TO EXTEND TIME to Respond to the Amended Complaint to February 6, 2025 - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 01/21/2025)
2025-01-21
1
SO ORDERED, re 46 STIPULATION TO EXTEND TIME to Respond to the Amended Complaint to February 6, 2025, filed by Beckman Coulter, Inc. Reset Answer Deadlines: Cytek Biosciences, Inc. answer due 2/6/2025. Ordered by Judge Colm F. Connolly on 1/22/2025. (kmd)
2025-01-22
1
No Actions
SO ORDERED AND ~Util - Set/Reset Answer Deadline
2025-01-22
1
No Actions
STIPULATION and [Proposed] Order Amending Scheduling Order by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 02/06/2025)
2025-02-06
1
ANSWER to Amended Complaint, re: 42 Amended Complaint, with Jury Demand, COUNTERCLAIM against Beckman Coulter, Inc. by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 02/06/2025)
2025-02-06
1
SO ORDERED, re 47 Stipulation Amending Scheduling Order, filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 2/7/2025. (kmd) (Entered: 02/07/2025)
2025-02-07
1
NOTICE OF SERVICE of Plaintiff's Disclosure of Asserted Claims and Infringement Contentions filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 02/14/2025)
2025-02-14
1
ORAL ORDER REFERRING CASE to Magistrate Judge Eleanor G. Tennyson for all matters relating to discovery and the protective order. Ordered by Judge Colm F. Connolly on 2/26/2025. (mws)
2025-02-26
1
No Actions
Oral Order AND Order Referring Case to Magistrate Judge
2025-02-26
1
No Actions
ORAL ORDER - In light of the referral of discovery and protective order disputes to the undersigned, IT IS HEREBY ORDERED that counsel shall file a Motion for Teleconference to Resolve a Discovery or Protective Order Dispute if the parties are unable to resolve a discovery matter through good-faith efforts. The text for this motion can be found in the "Forms" section of Judge Tennyson's portion of the Court's website. After reviewing such motion, the Court will issue an order outlining the specific dispute procedure to be used. ORDERED by Judge Eleanor G. Tennyson on 2/27/2025. (lah) (Entered: 02/27/2025)
2025-02-27
1
ANSWER to 48 Answer to Amended Complaint, Counterclaim by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 02/27/2025)
2025-02-27
1
Oral Order
2025-02-27
1
No Actions
STIPULATION and [Proposed] Order Amending Scheduling Order by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 02/28/2025)
2025-02-28
1
MOTION for Teleconference to Resolve Discovery Dispute - filed by Cytek Biosciences, Inc.. Motions referred to Eleanor G. Tennyson.(Clark, Cameron) (Entered: 03/03/2025)
2025-03-03
1
SO ORDERED, re 53 STIPULATION Amending Scheduling Order. Reset Scheduling Order Deadlines: (Fact Discovery completed by 10/8/2025. Expert Discovery due by 2/6/2026. A Markman Hearing is set for 8/21/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly). Signed by Judge Colm F. Connolly on 3/4/2025. (mws) (Entered: 03/04/2025)
2025-03-04
1
NOTICE of Subpoenas to Diasorin, Inc. and Luminex Corp. by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Tigan, Jeremy) (Entered: 03/04/2025)
2025-03-04
1
ORAL ORDER - Having reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 54 ), IT IS HEREBY ORDERED that a teleconference is set for Friday, March 21, 2025 at 11:00 AM before Judge Eleanor G. Tennyson. On or before 12:00 PM on March 14, 2025, Defendant shall file with the Court a letter not to exceed three (3) pages in no less than 12-point font outlining the issues in dispute and its position on those issues. Defendant shall attach to its letter a draft order that identifies with specificity the relief sought on an issue-by-issue basis. On or before 12:00 PM on March 18, 2025, Plaintiff may file a letter not to exceed three (3) pages in no less than 12-point font outlining its opposition. All letters shall comply with the requirements of Local Rule 37.1. Counsel shall provide a dial-in number for the teleconference by emailing egt_civil@ded.uscourts.gov. ORDERED by Judge Eleanor G. Tennyson on 3/5/2025. (lah) (Entered: 03/05/2025)
2025-03-05
1
Oral Order AND ~Util - Set Hearings
2025-03-05
1
No Actions
NOTICE of Subpoenas to Radiation Monitoring Devices, Inc. by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 03/11/2025)
2025-03-11
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Second Set of Requests for Production to Plaintiff Beckman Coulter, Inc. (Nos. 49-70) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 03/12/2025)
2025-03-12
1
ORAL ORDER: The start time for the Markman Hearing scheduled for 8/21/2025 has been moved from 9:00 AM to 1:00 PM (A Markman Hearing is set for 8/21/2025 at 01:00 PM in Courtroom 4B before Judge Colm F. Connolly). Ordered by Judge Colm F. Connolly on 3/13/2025. (mws)
2025-03-13
1
No Actions
Oral Order AND Set/Reset Scheduling Order Deadlines
2025-03-13
1
No Actions
[SEALED] Letter to The Honorable Eleanor G. Tennyson from Jeremy A. Tigan regarding Discovery Dispute - re 57 Oral Order,,,, Set Hearings,,,. (Attachments: # 1 Proposed Order, # 2 Exhibits A-G)(Tigan, Jeremy) (Entered: 03/14/2025)
2025-03-14
1
[SEALED] Letter to The Honorable Eleanor G. Tennyson from Frederick L. Cottrell III regarding Discovery Dispute - re 57 Oral Order,,,, Set Hearings,,,. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1-24)(Cottrell, Frederick) (Entered: 03/18/2025)
2025-03-18
1
ORAL ORDER - The Discovery Teleconference previously scheduled for 3/21/2025 is HEREBY RESET for 3/24/2025 at 02:00 PM before Judge Eleanor G. Tennyson. ORDERED by Judge Eleanor G. Tennyson on 3/20/2025. (lah) (Entered: 03/20/2025)
2025-03-20
1
Oral Order AND ~Util - Set Hearings
2025-03-20
1
No Actions
REDACTED VERSION of 60 Letter by Cytek Biosciences, Inc.. (Attachments: # 1 Proposed Order, # 2 Exhibits A-G)(Tigan, Jeremy) (Entered: 03/21/2025)
2025-03-21
1
ORAL ORDER re 54 - Defendant's request for case narrowing is GRANTED-IN-PART and DENIED-IN-PART. The transcript shall serve as the Court's ruling. ORDERED by Judge Eleanor G. Tennyson on 3/24/2025. (lah) (Entered: 03/24/2025)
2025-03-24
1
Minute Entry for proceedings held before Judge Eleanor G. Tennyson - Discovery Dispute Teleconference held on 3/24/2025. (Court Reporter Dale Hawkins.) (lah)
2025-03-24
1
No Actions
Discovery Conference
2025-03-24
1
No Actions
Order on Motion for Miscellaneous Relief
2025-03-24
1
No Actions
STIPULATION TO EXTEND TIME to file a redacted version of DI61 to March 27, 2025 - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 03/25/2025)
2025-03-25
1
SO ORDERED, re 65 STIPULATION TO EXTEND TIME to file a redacted version of DI61 to March 27, 2025, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 3/27/2025. (kmd) (Entered: 03/27/2025)
2025-03-27
1
REDACTED VERSION of 61 Letter by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1-24)(Cottrell, Frederick) (Entered: 03/27/2025)
2025-03-27
1
NOTICE OF SERVICE of Plaintiff Beckman Coulter, Inc.s Initial Election of Asserted Claims filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 04/02/2025)
2025-04-02
1
[SEALED] OBJECTIONS by Beckman Coulter, Inc. to 64 Order on Motion for Miscellaneous Relief . (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Certification to Objections to Order on Case Narrowing, # 4 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/07/2025)
2025-04-07
1
Official Transcript of Discovery Dispute Teleconference held on 03/24/2025 before Judge Eleanor G. Tennyson. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/30/2025. Redacted Transcript Deadline set for 5/12/2025. Release of Transcript Restriction set for 7/8/2025. (dh) (Entered: 04/09/2025)
2025-04-09
1
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding enclosing courtesy copies of discovery dispute letters - re 60 Letter, 61 Letter. (Cottrell, Frederick) (Entered: 04/09/2025)
2025-04-09
1
NOTICE OF SERVICE of Plaintiff's First Supplemental Objections and Responses to Defendant's First Set of Interrogatories (Nos. 1-12) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 04/11/2025)
2025-04-11
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Second Set of Interrogatories to Plaintiff Beckman Coulter, Inc. (Nos. 13-19) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 04/14/2025)
2025-04-14
1
REDACTED VERSION of 69 Objections, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Certification, # 4 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/14/2025)
2025-04-14
1
NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant's Second Set of Requests for Production (Nos. 49-70) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 04/17/2025)
2025-04-17
1
RESPONSE TO OBJECTIONS by Cytek Biosciences, Inc. re 69 Objections, . (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 04/21/2025)
2025-04-21
1
NOTICE OF SERVICE of Cytek Biosciences, Inc.'s Initial Invalidity Contentions filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 04/21/2025)
2025-04-21
1
NOTICE OF SERVICE of (1) Defendant Cytek Biosciences, Inc.'s First Amended Rule 26(a)(1) Initial Disclosures; and (2) Cytek's First Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 04/29/2025)
2025-04-29
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Identification of Claim Terms for Construction filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 04/29/2025)
2025-04-29
1
[SEALED] NOTICE of Subpoenas to Becton, Dickinson and Company by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Tigan, Jeremy) (Entered: 04/30/2025)
2025-04-30
1
REDACTED VERSION of 80 Notice (Other) by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Tigan, Jeremy) (Entered: 05/01/2025)
2025-05-01
1
NOTICE OF SERVICE of Plaintiffs Second Supplemental Objections and Responses to Defendants First Set of Interrogatories (Nos. 1-12) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 05/09/2025)
2025-05-09
1
NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant's Second Set of Interrogatories (Nos. 13-19) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 05/14/2025)
2025-05-14
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Supplemental Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 5, 7) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 05/14/2025)
2025-05-14
1
NOTICE OF SERVICE of Plaintiff's Identification of Claim Construction Issues and Proposed Constructions filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 05/14/2025)
2025-05-14
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Proposed Claim Constructions filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 05/14/2025)
2025-05-14
1
STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 05/23/2025)
2025-05-23
1
SO ORDERED, re 87 STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates, filed by Cytek Biosciences, Inc. Reset Deadlines for Claim Construction Briefing: Claim Construction Opening Brief due by 6/5/2025. Claim Construction Answering Brief due by 6/26/2025. Claim Construction Reply Brief due by 7/10/2025. Claim Construction Surreply Brief due by 7/24/2025. Signed by Judge Colm F. Connolly on 5/27/2025. (kmd) (Entered: 05/27/2025)
2025-05-27
1
CLAIM Construction Chart by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Farnan, Kelly) (Entered: 05/28/2025)
2025-05-28
1
MOTION for Claim Construction re 89 Claim Construction Chart - filed by Beckman Coulter, Inc. (Farnan, Kelly) (Entered: 05/28/2025)
2025-05-28
1
MOTION Claim Construction re 89 Claim Construction Chart - filed by Cytek Biosciences, Inc.(Jacobs, Karen) (Entered: 05/28/2025)
2025-05-28
1
Motions No Longer Referred: The automatic referrals generated by the system have been removed for 90 MOTION for Claim Construction and 91 MOTION Claim Construction. (mws)
2025-05-29
1
No Actions
Motions No Longer Referred
2025-05-29
1
No Actions
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Supplemental Reponses and Objections to Plaintiff's First Set of Interrogatories (No. 1) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 05/30/2025)
2025-05-30
1
NOTICE of Subpoena to Yong Qin Chen by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit 1)(Jacobs, Karen) (Entered: 06/05/2025)
2025-06-05
1
MOTION for Discovery Teleconference to Resolve Discovery Disputes - filed by Beckman Coulter, Inc.. Motions referred to Eleanor G. Tennyson.(Haynes, Christine) (Entered: 06/12/2025)
2025-06-12
1
ORAL ORDER - Having reviewed the Motion for Teleconference to Resolve Discovery Disputes (D.I. 94 ), IT IS HEREBY ORDERED that a teleconference is set for Friday, June 27, 2025 at 2:00 PM before Judge Eleanor G. Tennyson. On or before 11:00 AM on June 20, 2025, Plaintiff shall file with the Court a letter not to exceed three (3) pages in no less than 12-point font outlining the issues in dispute and its position on those issues. Plaintiff shall attach to its letter a draft order that identifies with specificity the relief sought on an issue-by-issue basis. On or before 11:00 AM on June 24, 2025, Defendant may file a letter not to exceed three (3) pages in no less than 12-point font outlining its opposition. All letters shall comply with the requirements of Local Rule 37.1. Counsel shall provide a dial-in number for the teleconference by emailing egt_civil@ded.uscourts.gov. ORDERED by Judge Eleanor G. Tennyson on 6/13/2025. (Entered: 06/13/2025)
2025-06-13
1
NOTICE OF SERVICE of Plaintiff's Second Set of Requests for Production of Documents and Things to Defendant Cytek Biosciences, Inc. (Nos. 151-276) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 06/13/2025)
2025-06-13
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Supplemental Reponses and Objections to Plaintiff's First Set of Interrogatories (No. 2) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 06/13/2025)
2025-06-13
1
Oral Order
2025-06-13
1
No Actions
[SEALED] Letter to The Honorable Eleanor G. Tennyson from Frederick L. Cottrell, III regarding Discovery Dispute - re 94 MOTION for Discovery Teleconference to Resolve Discovery Disputes. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Cottrell, Frederick) (Entered: 06/20/2025)
2025-06-20
1
Set Hearings - a telephonic discovery conference is set for 6/27/2025 at 02:00 PM before Judge Eleanor G. Tennyson. (lah)
2025-06-23
1
No Actions
Set/Reset Hearings
2025-06-23
1
No Actions
Letter to The Honorable Eleanor G. Tennyson from Jeremy A. Tigan regarding Response to Beckman Coulter's June 20, 2025 Letter - re 98 Letter,. (Attachments: # 1 Exhibits 1-6)(Tigan, Jeremy) (Entered: 06/24/2025)
2025-06-24
1
NOTICE OF SERVICE of (1) Defendant's Answering Claim Construction Brief; and (2) Declaration of Dustin M. Knight in Support of Defendant's Answering Claim Construction Brief filed by Cytek Biosciences, Inc..(Clark, Cameron) (Entered: 06/27/2025)
2025-06-27
1
ORAL ORDER re 94 - The motion for teleconference to resolve discovery disputes is GRANTED-IN-PART and DENIED-IN-PART. The transcript shall serve as the Court's ruling. ORDERED by Judge Eleanor G. Tennyson on 6/27/2025. (lah) (Entered: 06/27/2025)
2025-06-27
1
Minute Entry for proceedings held before Judge Eleanor G. Tennyson - Teleconference held on 6/27/2025. (Court Reporter Stacy Ingram.) (lah)
2025-06-27
1
No Actions
Discovery Conference
2025-06-27
1
No Actions
Order on Motion for Discovery
2025-06-27
1
No Actions
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
1
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
REDACTED VERSION of 98 Letter, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Text of Proposed Order)(Haynes, Christine) (Entered: 06/30/2025)
2025-06-30
2
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Third Set of Requests for Production to Plaintiff Beckman Coulter, Inc. (Nos. 71-77) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 07/03/2025)
2025-07-03
1
Unopposed MOTION and [Proposed] Order to Extend Time - filed by Beckman Coulter, Inc.. Motion no longer referred to Eleanor G. Tennyson.(Farnan, Kelly) Modified on 7/7/2025 (mws). (Entered: 07/03/2025)
2025-07-03
1
SO ORDERED, re 104 Unopposed MOTION to Extend Time filed by Beckman Coulter, Inc. Reset Deadlines for Claim Construction Briefing: (Claim Construction Reply Brief due by 7/11/2025. Claim Construction Surreply Brief due by 7/25/2025. Joint Claim Construction Brief due by 7/27/2025). Signed by Judge Colm F. Connolly on 7/7/2025. (mws) (Entered: 07/07/2025)
2025-07-07
1
Motions No Longer Referred: 104 Unopposed MOTION and [Proposed] Order to Extend Time: the automatic referral generated by CM/ECF has been removed for this motion. (mws)
2025-07-07
1
No Actions
Motions No Longer Referred
2025-07-07
1
No Actions
Official Transcript of Hearing held on 06-27-25 before Judge Tennyson. Court Reporter Stacy Ingram,Email: stacy_ingram@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/4/2025. Redacted Transcript Deadline set for 8/14/2025. Release of Transcript Restriction set for 10/14/2025. (Ingram, Stacy) (Entered: 07/14/2025)
2025-07-14
1
MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims - filed by Cytek Biosciences, Inc.. (Attachments: # 1 Text of Proposed Order)(Jacobs, Karen) (Entered: 07/22/2025)
2025-07-22
1
OPENING BRIEF in Support re 107 MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims filed by Cytek Biosciences, Inc..Answering Brief/Response due date per Local Rules is 8/5/2025. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 07/22/2025)
2025-07-22
1
DECLARATION of Reuben Chen re 107 MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Jacobs, Karen) (Entered: 07/22/2025)
2025-07-22
1
MOTION for Pro Hac Vice Appearance of Attorney Alissa Wood - filed by Cytek Biosciences, Inc.. (Jacobs, Karen) (Entered: 07/23/2025)
2025-07-23
1
Pro Hac Vice Fee - Credit Card Payment received for Alissa Wood. ( re 110 MOTION for Pro Hac Vice Appearance of Attorney Alissa Wood )( Payment of $ 50, receipt number ADEDC-4741415).(Jacobs, Karen) (Entered: 07/23/2025)
2025-07-23
1
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2025-07-23
1
No Actions
SO ORDERED, re 110 MOTION for Pro Hac Vice Appearance of Attorney Alissa Wood, filed by Cytek Biosciences, Inc. Ordered by Judge Colm F. Connolly on 7/24/2025. (kmd)
2025-07-24
1
No Actions
SO ORDERED
2025-07-24
1
No Actions
ANSWERING BRIEF in Opposition re 107 MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims filed by Beckman Coulter, Inc..Reply Brief due date per Local Rules is 8/1/2025. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Cottrell, Frederick) (Entered: 07/25/2025)
2025-07-25
1
ANSWERING BRIEF in Opposition re 107 MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims filed by Beckman Coulter, Inc..Reply Brief due date per Local Rules is 8/1/2025. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Cottrell, Frederick) (Entered: 07/25/2025)
2025-07-25
2
ANSWERING BRIEF in Opposition re 107 MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims filed by Beckman Coulter, Inc..Reply Brief due date per Local Rules is 8/1/2025. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Cottrell, Frederick) (Entered: 07/25/2025)
2025-07-25
2
ANSWERING BRIEF in Opposition re 107 MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims filed by Beckman Coulter, Inc..Reply Brief due date per Local Rules is 8/1/2025. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Cottrell, Frederick) (Entered: 07/25/2025)
2025-07-25
2
ANSWERING BRIEF in Opposition re 107 MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims filed by Beckman Coulter, Inc..Reply Brief due date per Local Rules is 8/1/2025. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Cottrell, Frederick) (Entered: 07/25/2025)
2025-07-25
2
ANSWERING BRIEF in Opposition re 107 MOTION to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims filed by Beckman Coulter, Inc..Reply Brief due date per Local Rules is 8/1/2025. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Cottrell, Frederick) (Entered: 07/25/2025)
2025-07-25
2
EXHIBIT re 112 Answering Brief in Opposition, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit E, # 2 Exhibit F, # 3 Exhibit G, # 4 Exhibit H, # 5 Exhibit I)(Cottrell, Frederick) (Entered: 07/25/2025)
2025-07-25
1
JOINT CLAIM CONSTRUCTION BRIEF filed by Beckman Coulter, Inc.. (Farnan, Kelly) (Entered: 07/27/2025)
2025-07-27
1
APPENDIX re 114 Joint Claim Construction Brief by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 21, # 21 Exhibit 22, # 22 Exhibit 23, # 23 Exhibit 24, # 24 Exhibit 25, # 25 Exhibit 26, # 26 Exhibit 27, # 27 Exhibit 28, # 28 Exhibit 29, # 29 Exhibit 30, # 30 Exhibit 31)(Farnan, Kelly) (Entered: 07/27/2025)
2025-07-27
1
Joint APPENDIX re 115 Appendix,, Volume II (Exhibits 32-54) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 32, # 2 Exhibit 33, # 3 Exhibit 34, # 4 Exhibit 35, # 5 Exhibit 36, # 6 Exhibit 37, # 7 Exhibit 38, # 8 Exhibit 39, # 9 Exhibit 40, # 10 Exhibit 41, # 11 Exhibit 42, # 12 Exhibit 43, # 13 Exhibit 44, # 14 Exhibit 45, # 15 Exhibit 46, # 16 Exhibit 47, # 17 Exhibit 48, # 18 Exhibit 49, # 19 Exhibit 50, # 20 Exhibit 51, # 21 Exhibit 52, # 22 Exhibit 53, # 23 Exhibit 54)(Farnan, Kelly) (Entered: 07/27/2025)
2025-07-27
1
Joint EXHIBIT re 115 Appendix,, Volume III (Exhibits 55-90) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 55, # 2 Exhibit 56, # 3 Exhibit 57, # 4 Exhibit 58, # 5 Exhibit 59, # 6 Exhibit 60, # 7 Exhibit 61, # 8 Exhibit 62, # 9 Exhibit 63, # 10 Exhibit 64, # 11 Exhibit 65, # 12 Exhibit 66, # 13 Exhibit 67, # 14 Exhibit 68, # 15 Exhibit 69, # 16 Exhibit 70, # 17 Exhibit 71, # 18 Exhibit 72, # 19 Exhibit 73, # 20 Exhibit 74, # 21 Exhibit 75, # 22 Exhibit 76, # 23 Exhibit 77, # 24 Exhibit 78, # 25 Exhibit 79, # 26 Exhibit 80, # 27 Exhibit 81, # 28 Exhibit 82, # 29 Exhibit 83, # 30 Exhibit 84, # 31 Exhibit 85, # 32 Exhibit 86, # 33 Exhibit 87, # 34 Exhibit 88, # 35 Exhibit 89, # 36 Exhibit 90)(Farnan, Kelly) (Entered: 07/27/2025)
2025-07-27
1
[SEALED] Joint EXHIBIT re 115 Appendix,, (Exhibit 20) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 20)(Farnan, Kelly) (Entered: 07/27/2025)
2025-07-27
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Supplemental Responses to Beckman's First Set of Interrogatories (Nos. 1, 4, 9, 11, 12, 13) filed by Cytek Biosciences, Inc..(Jacobs, Karen) (Entered: 07/28/2025)
2025-07-28
1
NOTICE OF SERVICE of Cytek's Sur-Reply Claim Construction Brief filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 07/28/2025)
2025-07-28
1
NOTICE OF SERVICE of Cytek Biosciences, Inc.'s Responses and Objections to Plaintiff's Second Set of Requests for Production of Documents and Things (Nos. 151-276) filed by Cytek Biosciences, Inc..(Jacobs, Karen) (Entered: 07/29/2025)
2025-07-29
1
MOTION for Pro Hac Vice Appearance of Attorney HanByul Chang - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 07/29/2025)
2025-07-29
1
Pro Hac Vice Fee - Credit Card Payment received for HanByul Chang. ( re 122 MOTION for Pro Hac Vice Appearance of Attorney HanByul Chang )( Payment of $ 50, receipt number ADEDC-4745655).(Tigan, Jeremy) (Entered: 07/29/2025)
2025-07-29
1
SO ORDERED, re 122 MOTION for Pro Hac Vice Appearance of Attorney HanByul Chang, filed by Cytek Biosciences, Inc. Ordered by Judge Colm F. Connolly on 7/29/2025. (kmd)
2025-07-29
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2025-07-29
1
No Actions
SO ORDERED
2025-07-29
1
No Actions
ORDER: The Motion to Stay Pending Inter Partes Review and Post Grant Review of the Asserted Patent Claims (D.I. 107 ) filed by Defendant Cytek Biosciences, Inc. is DENIED. Signed by Judge Colm F. Connolly on 7/30/2025. (mws) (Entered: 07/30/2025)
2025-07-30
1
STIPULATION TO EXTEND TIME for the parties to file an amended joint claim construction chart to August 1, 2025 - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 07/30/2025)
2025-07-30
1
SO ORDERED, re 125 STIPULATION TO EXTEND TIME for the parties to file an amended joint claim construction chart to August 1, 2025, filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 7/31/2025. (kmd) (Entered: 07/31/2025)
2025-07-31
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Fourth Set of Requests for Production to Plaintiff Beckman Coulter, Inc. (Nos. 78-100) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 08/01/2025)
2025-08-01
1
NOTICE of Subpoena by Cytek Biosciences, Inc. (Tigan, Jeremy) (Entered: 08/01/2025)
2025-08-01
1
NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant's Third Set of Requests for Production (Nos. 71-77) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 08/01/2025)
2025-08-01
1
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding amended joint claim construction chart. (Cottrell, Frederick) (Entered: 08/01/2025)
2025-08-01
1
CLAIM Construction Chart by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Cottrell, Frederick) (Main Document 131 replaced on 8/12/2025) (mws). (Attachment 1 replaced on 8/12/2025) (mws). (Entered: 08/01/2025)
2025-08-01
1
NOTICE OF SERVICE of Plaintiffs Third Supplemental Objections & Responses to Defendants First Set of Interrogatories (Nos. 1-12) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 08/04/2025)
2025-08-04
1
NOTICE of Supplemental Authority in Support of Claim Construction by Beckman Coulter, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Cottrell, Frederick) (Entered: 08/07/2025)
2025-08-07
1
NOTICE of Supplemental Authority in Support of Claim Construction by Beckman Coulter, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Cottrell, Frederick) (Entered: 08/07/2025)
2025-08-07
2
NOTICE of Supplemental Authority in Support of Claim Construction by Beckman Coulter, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Cottrell, Frederick) (Entered: 08/07/2025)
2025-08-07
2
STATEMENT re 133 Notice (Other) -- Cytek Biosciences, Inc.'s Response to Beckman Coulter, Inc.'s August 7, 2025 Notice of Supplemental Authority -- by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 08/08/2025)
2025-08-08
1
NOTICE OF SERVICE of Plaintiffs Objections & Responses to Defendants Third Set of Interrogatories (Nos. 20-21) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 08/11/2025)
2025-08-11
1
Remark: PDF of the main document and Exhibit A of D.I. 131 replaced at request of counsel to correct a pagination error. The main document had inadvertently included the first two pages of Exhibit A prior to correction. (mws)
2025-08-12
1
No Actions
Remark
2025-08-12
1
No Actions
NOTICE OF SERVICE of Second Set of Interrogatories to Defendant Cytek Biosciences, Inc. (Nos. 16-21) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 08/13/2025)
2025-08-13
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Sixth Supplemental Responses and Objections to Plaintiff's First Set of Interrogatories (No. 5) and Exhibits A-D filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 08/18/2025)
2025-08-18
1
NOTICE of Subpoena to Yong Qin Chen by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit 1)(Clark, Cameron) (Entered: 08/18/2025)
2025-08-18
1
NOTICE of Subpoena to Yong Qin Chen by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit 1)(Clark, Cameron) (Entered: 08/18/2025)
2025-08-18
2
MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)Motions referred to Eleanor G. Tennyson.(Haynes, Christine) (Entered: 08/19/2025)
2025-08-19
1
NOTICE of Subpoena to Foreal Spectrum, Inc. by Beckman Coulter, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 08/19/2025)
2025-08-19
1
NOTICE of Subpoena to Photop Technologies, Inc. by Beckman Coulter, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 08/19/2025)
2025-08-19
1
Motions No Longer Referred: 139 MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices no longer referred to Judge Tennyson. (lah)
2025-08-19
1
No Actions
Motions No Longer Referred
2025-08-19
1
No Actions
ORDER granting in part 139 MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices. Signed by Judge Colm F. Connolly on 8/20/2025. (kmd) (Entered: 08/20/2025)
2025-08-20
1
NOTICE to Take Deposition of Dave Vrane on September 22, 2025 filed by Beckman Coulter, Inc..(Farnan, Kelly) (Entered: 08/21/2025)
2025-08-21
1
NOTICE to Take Deposition of Qing Shao on September 23, 2025 filed by Beckman Coulter, Inc..(Farnan, Kelly) (Entered: 08/21/2025)
2025-08-21
1
NOTICE to Take Deposition of Melik Ulusu on September 24, 2025 filed by Beckman Coulter, Inc..(Farnan, Kelly) (Entered: 08/21/2025)
2025-08-21
1
NOTICE to Take Deposition of Ginestet Araki on September 26, 2025 filed by Beckman Coulter, Inc..(Farnan, Kelly) (Entered: 08/21/2025)
2025-08-21
1
NOTICE to Take Deposition of Patrik Jeanmonod on September 29, 2025 filed by Beckman Coulter, Inc..(Farnan, Kelly) (Entered: 08/21/2025)
2025-08-21
1
NOTICE to Take Deposition of David Kennedy on September 30, 2025 filed by Beckman Coulter, Inc..(Farnan, Kelly) (Entered: 08/21/2025)
2025-08-21
1
NOTICE to Take Deposition of Ming Yan on October 1, 2025 filed by Beckman Coulter, Inc..(Farnan, Kelly) (Entered: 08/21/2025)
2025-08-21
1
NOTICE to Take Deposition of Bing Shan on October 2, 2025 filed by Beckman Coulter, Inc..(Farnan, Kelly) (Entered: 08/21/2025)
2025-08-21
1
Set/Reset Deadlines: Supplemental Joint Claim Construction Brief due by 9/10/2025. (mws)
2025-08-21
1
No Actions
ORAL ORDER: Per agreement by the parties at the 8/21/2025 Markman Hearing, the Objections filed by Beckman Coulter, Inc. (D.I. 69 ) are overruled as moot. Ordered by Judge Colm F. Connolly on 8/21/2025. (mws)
2025-08-21
1
No Actions
Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 8/21/2025. (Court Reporter Bonnie Archer.) (mws)
2025-08-21
1
No Actions
Set Hearings: A Markman Hearing is set for 9/17/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. (mws)
2025-08-21
1
No Actions
Set/Reset Hearings
2025-08-21
1
No Actions
Markman Hearing
2025-08-22
1
No Actions
Oral Order
2025-08-22
1
No Actions
Set/Reset Deadlines
2025-08-22
1
No Actions
Official Transcript of Markman Hearing held on 8/21/2025 before Judge Colm F. Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/15/2025. Redacted Transcript Deadline set for 9/25/2025. Release of Transcript Restriction set for 11/24/2025. (mws) (Entered: 08/25/2025)
2025-08-25
1
MOTION for Pro Hac Vice Appearance of Attorney Juan Pablo Gonzalez - filed by Cytek Biosciences, Inc.. (Jacobs, Karen) (Entered: 08/25/2025)
2025-08-25
1
Pro Hac Vice Fee - Credit Card Payment received for Juan Pablo Gonzalez. ( re 152 MOTION for Pro Hac Vice Appearance of Attorney Juan Pablo Gonzalez )( Payment of $ 50, receipt number ADEDC-4774312).(Jacobs, Karen) (Entered: 08/25/2025)
2025-08-25
1
SO ORDERED, re 152 MOTION for Pro Hac Vice Appearance of Attorney Juan Pablo Gonzalez filed by Cytek Biosciences, Inc.. Ordered by Judge Colm F. Connolly on 8/25/2025. (mws)
2025-08-25
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2025-08-25
1
No Actions
SO ORDERED
2025-08-25
1
No Actions
NOTICE OF SERVICE of Plaintiffs Fourth Supplemental Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-12) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 08/26/2025)
2025-08-26
1
NOTICE OF SERVICE of Defendant's Notice of Deposition Under Federal Rule of Civil Procedure 30(b)(6) filed by Cytek Biosciences, Inc..(Jacobs, Karen) (Entered: 08/29/2025)
2025-08-29
1
NOTICE to Take Deposition of Ray Lannigan on October 7, 2025 filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 09/09/2025)
2025-09-09
1
NOTICE to Take Deposition of Al Hernandez on October 6, 2025 filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 09/09/2025)
2025-09-09
1
[SEALED] CLAIM CONSTRUCTION SURREPLY BRIEF /Cytek's Supplemental Claim Construction Brief filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 09/10/2025)
2025-09-10
1
[SEALED] DECLARATION of Dustin M. Knight in Support of Cytek's Supplemental Claim Construction Brief re 158 Claim Construction Surreply Brief by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 91, # 2 Exhibit 92, # 3 Exhibit 93, # 4 Exhibit 94)(Tigan, Jeremy) (Entered: 09/10/2025)
2025-09-10
1
[SEALED] STATEMENT [Supplemental Claim Construction Brief] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Certificate of Compliance)(Haynes, Christine) Modified on 9/11/2025 (mws). (Entered: 09/10/2025)
2025-09-10
1
[SEALED] STATEMENT [Supplemental Claim Construction Brief] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Certificate of Compliance)(Haynes, Christine) Modified on 9/11/2025 (mws). (Entered: 09/10/2025)
2025-09-10
2
[SEALED] STATEMENT [Supplemental Claim Construction Brief] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Certificate of Compliance)(Haynes, Christine) Modified on 9/11/2025 (mws). (Entered: 09/10/2025)
2025-09-10
2
[SEALED] STATEMENT [Supplemental Claim Construction Brief] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Certificate of Compliance)(Haynes, Christine) Modified on 9/11/2025 (mws). (Entered: 09/10/2025)
2025-09-10
2
[SEALED] STATEMENT [Supplemental Claim Construction Brief] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Certificate of Compliance)(Haynes, Christine) Modified on 9/11/2025 (mws). (Entered: 09/10/2025)
2025-09-10
2
[SEALED] STATEMENT [Supplemental Claim Construction Brief] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Certificate of Compliance)(Haynes, Christine) Modified on 9/11/2025 (mws). (Entered: 09/10/2025)
2025-09-10
2
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Second Amended Rule 26(a)(1) Initial Disclosures filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 09/12/2025)
2025-09-12
1
NOTICE OF SERVICE of (1) Plaintiffs Fifth Supplemental Objections & Responses to Defendants First Set of Interrogatories (Nos. 1-12) and (2) Plaintiffs First Supplemental Objections & Responses to Defendants Second Set of Interrogatories (Nos. 13-19) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 09/12/2025)
2025-09-12
1
NOTICE OF SERVICE of Cytek Biosciences, Inc.'s Notice of Rule 30(b)(1) Depositions of Xianghua Shi, Evgenia Kim, Jianhua Wang, Xiao Lv, and Xi Liu filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 09/15/2025)
2025-09-15
1
NOTICE OF SERVICE of (1) Defendant Cytek Biosciences, Inc.'s Seventh Supplemental Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 4, 6, 7, 8, and 9) and (2) Cytek Biosciences, Inc.'s Responses and Objections to Plaintiff's Second Set of Interrogatories (Nos. 16-21) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 09/15/2025)
2025-09-15
1
MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. Motions referred to Eleanor G. Tennyson.(Haynes, Christine) (Entered: 09/16/2025)
2025-09-16
1
MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)Motions referred to Eleanor G. Tennyson.(Haynes, Christine) (Entered: 09/16/2025)
2025-09-16
1
SO ORDERED, re 165 MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices, filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 9/16/2025. (kmd) (Entered: 09/16/2025)
2025-09-16
1
NOTICE OF SERVICE of (1) Defendant Cytek Biosciences, Inc.'s Fifth Set of Requests for Production to Plaintiff Beckman Coulter, Inc. (Nos. 101-111) and (2) Defendant Cytek Biosciences, Inc.'s Fourth Set of Interrogatories to Plaintiff Beckman Coulter, Inc. (Nos. 22-23) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 09/16/2025)
2025-09-16
1
ORAL ORDER. 166 MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices, filed by Beckman Coulter, Inc., is DENIED as to Michael Levy. Ordered by Judge Colm F. Connolly on 9/16/2025. (kmd)
2025-09-16
1
No Actions
Oral Order
2025-09-16
1
No Actions
REDACTED VERSION of 160 Statement, by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Haynes, Christine) (Entered: 09/17/2025)
2025-09-17
1
REDACTED VERSION of 160 Statement, by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Haynes, Christine) (Entered: 09/17/2025)
2025-09-17
2
REDACTED VERSION of 160 Statement, by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Haynes, Christine) (Entered: 09/17/2025)
2025-09-17
2
REDACTED VERSION of 160 Statement, by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Haynes, Christine) (Entered: 09/17/2025)
2025-09-17
2
REDACTED VERSION of 160 Statement, by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Haynes, Christine) (Entered: 09/17/2025)
2025-09-17
2
REDACTED VERSION of 160 Statement, by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Haynes, Christine) (Entered: 09/17/2025)
2025-09-17
2
REDACTED VERSION of 158 Claim Construction Surreply Brief by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 09/17/2025)
2025-09-17
1
REDACTED VERSION of 159 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 91-94)(Clark, Cameron) (Entered: 09/17/2025)
2025-09-17
1
REDACTED VERSION of 159 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 91-94)(Clark, Cameron) (Entered: 09/17/2025)
2025-09-17
2
Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 9/17/2025. (Court Reporter Bonnie Archer.) (mws)
2025-09-17
1
No Actions
Markman Hearing
2025-09-17
1
No Actions
NOTICE to Take Deposition of Wenbin Jiang on October 15, 2025 filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 09/18/2025)
2025-09-18
1
Official Transcript of Markman Hearing held on 9/17/2025 before Judge Colm F. Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/10/2025. Redacted Transcript Deadline set for 10/20/2025. Release of Transcript Restriction set for 12/18/2025. (mws) (Entered: 09/19/2025)
2025-09-19
1
NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests for Admission to Defendant Cytek Biosciences, Inc. (Nos. 1-35); (2) Plaintiff's Third Set of Interrogatories to Defendant Cytek Biosciences, Inc. (Nos. 22-25); (3) Plaintiff's Third Set of Requests for Production of Documents and Things to Defendant Cytek Biosciences, Inc. (Nos. 277-307); and (4) Plaintiff's Second Set of Requests for Admission to Defendant Cytek Biosciences, Inc. (Nos. 36-1,835) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 09/22/2025)
2025-09-22
1
NOTICE OF SERVICE of Plaintiff's Notice of Deposition to Cytek Biosciences, Inc. filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 09/25/2025)
2025-09-25
1
NOTICE OF SERVICE of (1) Plaintiff's Sixth Supplemental Objections & Responses to Defendant's First Set of Interrogatories (Nos. 1-12) and (2) Plaintiff's First Supplemental Objections & Responses to Defendant's Third Set of Interrogatories (Nos. 20-21) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 09/26/2025)
2025-09-26
1
STIPULATION and [Proposed] Order Amending Scheduling Order re 55 SO ORDERED,, Set/Reset Scheduling Order Deadlines,, Set Hearings, by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 09/29/2025)
2025-09-29
1
SO ORDERED, re 177 Stipulation Amending Scheduling Order, filed by Beckman Coulter, Inc. (See Order for Deadlines.) Signed by Judge Colm F. Connolly on 9/29/2025. (kmd) (Entered: 09/29/2025)
2025-09-29
1
[SEALED] NOTICE of Subpoenas to Lisa Nichols and Danaher Corporation by Cytek Biosciences, Inc. (Attachments: # 1 Exhibits 1-3)(Clark, Cameron) (Entered: 09/30/2025)
2025-09-30
1
NOTICE of Subpoena to Stanford University by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit 1)(Clark, Cameron) (Entered: 09/30/2025)
2025-09-30
1
NOTICE of Subpoena to Stanford University by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit 1)(Clark, Cameron) (Entered: 09/30/2025)
2025-09-30
2
NOTICE OF SERVICE of Plaintiffs Second Election of Asserted Claims filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 10/01/2025)
2025-10-01
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Third Amended Rule 26(A)(1) Initial Disclosures filed by Cytek Biosciences, Inc..(Jacobs, Karen) (Entered: 10/03/2025)
2025-10-03
1
REDACTED VERSION of 179 Notice (Other) by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibits 1-3)(Clark, Cameron) (Entered: 10/07/2025)
2025-10-07
1
REDACTED VERSION of 179 Notice (Other) by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibits 1-3)(Clark, Cameron) (Entered: 10/07/2025)
2025-10-07
2
SUBPOENA filed by Beckman Coulter, Inc. directed to Jay Hsieh for Production of Documents and Deposition for October 22, 2025 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Haynes, Christine) (Entered: 10/07/2025)
2025-10-07
1
NOTICE OF SERVICE of (1) Non-Party Greg Milosevich Objections & Responses to Defendant's Subpoena to Testify and (2) Non-Party Greg Milosevich Objections & Responses to Defendant's Subpoena to Produce Documents, Information, or Objects (Nos. 1-11) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 10/10/2025)
2025-10-10
1
MOTION for Pro Hac Vice Appearance of Attorney Kelly A. Todd, Laura Macro, Akkad Y. Moussa, and Maggie Sawin - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 10/15/2025)
2025-10-15
1
Pro Hac Vice Fee - Credit Card Payment received for Kelly A. Todd, Laura Macro, Akkad Y. Moussa, and Maggie Sawin. ( re 186 MOTION for Pro Hac Vice Appearance of Attorney Kelly A. Todd, Laura Macro, Akkad Y. Moussa, and Maggie Sawin )( Payment of $ 200, receipt number ADEDC-4813234).(Haynes, Christine) (Entered: 10/15/2025)
2025-10-15
1
SO ORDERED, re 186 MOTION for Pro Hac Vice Appearance of Attorney Kelly A. Todd, Laura Macro, Akkad Y. Moussa, and Maggie Sawin, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 10/15/2025. (kmd)
2025-10-15
1
No Actions
-District Court Pro Hac Vice Fee - 04 Attorneys Credit Card Payment
2025-10-15
1
No Actions
SO ORDERED
2025-10-15
1
No Actions
NOTICE OF SERVICE of (1) Plaintiffs Objections & Responses to Defendants Fourth Set of Interrogatories (Nos. 22-23) and (2) Plaintiffs Objections & Responses to Defendants Fifth Set of Requests for Production (Nos. 101-111) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 10/16/2025)
2025-10-16
1
NOTICE OF SERVICE of SUBPOENA filed by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 10/21/2025)
2025-10-21
1
NOTICE OF SERVICE of SUBPOENA filed by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 10/21/2025)
2025-10-21
2
Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Request for Status Conference. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 10/23/2025)
2025-10-23
1
Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Request for Status Conference. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 10/23/2025)
2025-10-23
2
NOTICE OF SERVICE of Cytek's Responses and Objections to Plaintiff's Third Set of Requests for Production of Documents and Things (Nos. 277-307) filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 10/24/2025)
2025-10-24
1
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell III regarding Tocytek Biosciences, Inc.'s Request For a Status Conference - re 190 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Cottrell, Frederick) (Entered: 10/24/2025)
2025-10-24
1
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell III regarding Tocytek Biosciences, Inc.'s Request For a Status Conference - re 190 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Cottrell, Frederick) (Entered: 10/24/2025)
2025-10-24
2
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell III regarding Tocytek Biosciences, Inc.'s Request For a Status Conference - re 190 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Cottrell, Frederick) (Entered: 10/24/2025)
2025-10-24
2
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell III regarding Tocytek Biosciences, Inc.'s Request For a Status Conference - re 190 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Cottrell, Frederick) (Entered: 10/24/2025)
2025-10-24
2
NOTICE OF SERVICE of (1) Plaintiffs Second Amended Disclosures Under Paragraph 3 of the Delaware Default Standard for Discovery and Rule 26(a)(1) of the Federal Rules of Civil Procedure; (2) Plaintiffs First Supplemental Objections and Responses to Defendants Second Set of Interrogatories (Nos. 13-19); (3) Plaintiffs First Supplemental Objections and Responses to Defendants Fourth Set of Interrogatories (Nos. 22-23); (4) Plaintiffs Second Supplemental Objections and Responses to Defendants Third Set of Interrogatories (Nos. 20-21); and (5) Plaintiffs Seventh Supplemental Objections and Responses to Defendants First Set of Interrogatories (Nos. 1-12) filed by Beckman Coulter, Inc..(Cottrell, Frederick) (Entered: 10/24/2025)
2025-10-24
1
NOTICE OF SERVICE of (1) Plaintiffs Objections and Responses to Defendants Fifth Set of Interrogatories (Nos. 24-25) and (2) Plaintiffs Objections and Responses to Defendants First Set of Requests for Admission filed by Beckman Coulter, Inc..(Cottrell, Frederick) (Entered: 10/24/2025)
2025-10-24
1
Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Reply Letter regarding Early Summary Judgment - re 192 Letter,. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 10/27/2025)
2025-10-27
1
Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Reply Letter regarding Early Summary Judgment - re 192 Letter,. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 10/27/2025)
2025-10-27
2
NOTICE requesting Clerk to remove Alissa Wood as co-counsel. Reason for request: No Longer With the Firm. (Tigan, Jeremy) (Entered: 10/27/2025)
2025-10-27
1
STIPULATION and [Proposed] Order Amending Scheduling Order re 178 SO ORDERED, Set Scheduling Order Deadlines by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 11/05/2025)
2025-11-05
1
SO ORDERED, re 197 STIPULATION Amending Scheduling Order filed by Beckman Coulter, Inc. Reset Scheduling Order Deadlines: (Expert Discovery due by 2/24/2026; Dispositive Motions due by 3/13/2026). Ordered by Judge Colm F. Connolly on 11/5/2025. (mws) (Entered: 11/05/2025)
2025-11-05
1
NOTICE OF SERVICE of Plaintiff's Eighth Supplemental Objections and Responses to Defendant's Frist Set of Interrogatories (Nos. 1-12), Second Supplemental Objections and Responses to Defendant's Second Set of Interrogatories (Nos. 13-19) and Second Supplemental Objections and Responses to Defendant's Fourth Set of Interrogatories (Nos. 22-23) filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 11/06/2025)
2025-11-06
1
ORAL ORDER: Having reviewed the parties competing letters (D.I. 190 ; D.I. 192 ; D.I. 195 ), it is HEREBY ORDERED that Defendant's request for a status conference and early summary judgment briefing is DENIED. Ordered by Judge Colm F. Connolly on 11/6/2025. (mws)
2025-11-06
1
No Actions
Oral Order
2025-11-06
1
No Actions
MOTION for Conference to Resolve Discovery Disputes - filed by Beckman Coulter, Inc.. Motions referred to Eleanor G. Tennyson.(Haynes, Christine) (Entered: 11/12/2025)
2025-11-12
1
ORAL ORDER - Having reviewed the Motion for Conference to Resolve Discovery Disputes (D.I. 200 ), IT IS HEREBY ORDERED that a hearing is set for November 24, 2025 at 4:00 PM before Judge Eleanor G. Tennyson in Courtroom 2B. Because the parties have only met and conferred for thirty minutes prior to raising these disputes, IT IS FURTHER ORDERED that the parties shall meet and confer again in good faith - with lead trial counsel for both sides present - in an attempt to reach a resolution. If unable to resolve the disputes, then on or before 11:00 AM on November 18, 2025, Defendant shall file with the Court a letter not to exceed three (3) pages in no less than 12-point font outlining the issues in dispute and its position on those issues. Defendant shall attach to its letter a draft order that identifies with specificity the relief sought on an issue-by-issue basis. On or before 11:00 AM on November 20, 2025, Plaintiff may file a letter not to exceed three (3) pages in no less than 12-point font outlining its opposition. All letters shall comply with the requirements of Local Rule 37.1. ORDERED by Judge Eleanor G. Tennyson on 11/13/2025. (mpb) (Entered: 11/13/2025)
2025-11-13
1
Oral Order AND ~Util - Set Hearings
2025-11-13
1
No Actions
ORAL ORDER - Counsel has contacted chambers requesting clarification of the Court's order (D.I. 201 ) setting a briefing schedule on the parties' discovery disputes. IT IS HEREBY ORDERED that the Court's November 13, 2025 oral order is MODIFIED as follows. On or before 11:00 AM on November 18, 2025, any party seeking relief shall file with the Court a letter not to exceed two (2) pages in no less than 12-point font outlining the issues in dispute and that party's position on those issues. The party seeking relief shall attach to its letter a draft order that identifies with specificity the relief sought by that party on an issue-by-issue basis. On or before 11:00 AM on November 20, 2025, any party opposing the application for relief may file a letter not to exceed two (2) pages in no less than 12-point font outlining that party's opposition. All letters shall comply with the requirements of Local Rule 37.1. IT IS FURTHER ORDERED that the rest of the Court's November 13, 2025 oral order remains in effect. ORDERED by Judge Eleanor G. Tennyson on 11/17/2025. (mpb) (Entered: 11/17/2025)
2025-11-17
1
Oral Order
2025-11-17
1
No Actions
STIPULATION and [Proposed] Order Permitting Plaintiff Leave to Serve Supplemental Infringement Contentions by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 11/18/2025)
2025-11-18
1
ORAL ORDER - Counsel has contacted chambers to inform the Court that the parties have resolved their pending discovery disputes. THEREFORE, IT IS HEREBY ORDERED that the motion for a conference to resolve discovery disputes (D.I. 200 ) is DENIED as MOOT, and the hearing scheduled for November 24, 2025 is CANCELLED. ORDERED by Judge Eleanor G. Tennyson on 11/18/2025. (mpb) (Entered: 11/18/2025)
2025-11-18
1
Order on Motion for Miscellaneous Relief
2025-11-18
1
No Actions
SO ORDERED, re 203 Stipulation Permitting Plaintiff Leave to Serve Supplemental Infringement Contentions, filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 11/19/2025. (kmd) (Entered: 11/19/2025)
2025-11-19
1
NOTICE OF SERVICE of Plaintiff's Second Amended Disclosure of Asserted Claims and Infringement Contentions filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 11/19/2025)
2025-11-19
1
STIPULATION Permitting Defendant Leave to Serve Supplemental Invalidity Contentions by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 12/16/2025)
2025-12-16
1
SO ORDERED, re 207 Stipulation Permitting Defendant Leave to Serve Supplemental Invalidity Contentions, filed by Cytek Biosciences, Inc. Signed by Judge Colm F. Connolly on 12/16/2025. (kmd) (Entered: 12/16/2025)
2025-12-16
1
STIPULATION and [Proposed] Order Amending Scheduling Order by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 12/17/2025)
2025-12-17
1
SO ORDERED, re 209 Stipulation Amending Scheduling Order, filed by Beckman Coulter, Inc. Reset Scheduling Order Deadlines: Opening Expert Reports due by 12/19/2025. Rebuttal Expert Reports due by 1/16/2026. Signed by Judge Colm F. Connolly on 12/18/2025. (kmd) (Entered: 12/18/2025)
2025-12-18
1
NOTICE OF SERVICE of (1) Opening Expert Report of Dr. David Schaafsma, PhD Regarding Infringement of U.S. Patent Nos. 10,330,582, 11.703,443, and 12,174,107; (2) Opening Expert Report of Dr. Jessica P. Houston, PhD Regarding Infringement of U.S. Patent Nos. 10,330,582, 11,703,443, and 12,174,107; and (3) Expert Report of Michele M. Riley filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 12/22/2025)
2025-12-22
1
NOTICE OF SERVICE of 1) Opening Invalidity Expert Report of Fedor A. Ilkov, Ph.D., 2) Opening Expert Report of Junichiro Kono, Ph.D., and 3) Opening Expert Report of Bernhard H. Weigl, Ph.D. filed by Cytek Biosciences, Inc..(Clark, Cameron) (Entered: 12/22/2025)
2025-12-22
1
NOTICE of Withdrawal of Asher McGuffin, Esquire by Beckman Coulter, Inc. (Haynes, Christine) (Entered: 12/31/2025)
2025-12-31
1
STIPULATION TO EXTEND TIME for Rebuttal and Reply Expert Reports to January 20, 2026 and February 9, 2026 - filed by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 01/14/2026)
2026-01-14
1
SO ORDERED, re 214 STIPULATION TO EXTEND TIME for Rebuttal and Reply Expert Reports to January 20, 2026 and February 9, 2026, filed by Cytek Biosciences, Inc. Reset Scheduling Order Deadlines: Rebuttal Expert Reports due by 1/20/2026. Reply Expert Reports due by 2/9/2026. Signed by Judge Colm F. Connolly on 1/15/2026. (kmd) (Entered: 01/15/2026)
2026-01-15
1
NOTICE OF SERVICE of 1) Rebuttal Expert Report of James F. Leary, Ph.D. Regarding Non-Infringement of U.S. Patent Nos. 10,330,582; 11,703,443; and 12,174,107 2) Rebuttal Expert Report of Fedor A. Ilkov, Ph.D. Regarding Non-Infringement of U.S. Patent Nos. 10,330,582; 11,703,443; and 12,174,107, and 3) Expert Rebuttal Report of John L. Hansen filed by Cytek Biosciences, Inc..(Clark, Cameron) (Entered: 01/21/2026)
2026-01-21
1
NOTICE OF SERVICE of (1) Rebuttal Expert Report of Dr. David Schaafsma, PhD Regarding Validity of U.S. Patent Nos. 10,330,582, 11.703,443, and 12,174,107; (2) Rebuttal Expert Report of Dr. Jessica Houston, PhD Regarding Validity of U.S. Patent Nos. 10,330,582, 11,703,443, and 12,174,107; (3) Rebuttal Expert Report of Dr. Michael S. Arnold; and (4) Rebuttal Expert Report of Joseph Paul Robinson Regarding Validity of U.S. Patent Nos. 10,330,582, 11,703,443, and 12,174,107 filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 01/21/2026)
2026-01-21
1
MOTION for Pro Hac Vice Appearance of Attorney Alexandra Leeper - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 01/30/2026)
2026-01-30
1
Pro Hac Vice Fee - Credit Card Payment received for Alexandra Leeper. ( re 218 MOTION for Pro Hac Vice Appearance of Attorney Alexandra Leeper )( Payment of $ 50, receipt number ADEDC-4889348).(Tigan, Jeremy) (Entered: 01/30/2026)
2026-01-30
1
Pro Hac Vice Attorney Alexandra Leeper for Cytek Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk)
2026-01-30
1
No Actions
SO ORDERED, re 218 MOTION for Pro Hac Vice Appearance of Attorney Alexandra Leeper filed by Cytek Biosciences, Inc. Ordered by Judge Colm F. Connolly on 1/30/2026. (mws)
2026-01-30
1
No Actions
Add Attorneys - PHV only
2026-01-30
1
No Actions
SO ORDERED
2026-01-30
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2026-01-30
1
No Actions
NOTICE OF SERVICE of 1) Reply Expert Report of James F. Leary, Ph.D., 2) Reply Invalidity Expert Report of Fedor A. Ilkov, Ph.D., 3) Reply Expert Rebuttal Report of Junichiro Kono, Ph.D., and 4) Reply Expert Report of Bernhard H. Weigl, Ph.D. filed by Cytek Biosciences, Inc..(Clark, Cameron) (Entered: 02/10/2026)
2026-02-10
1
NOTICE OF SERVICE of (1) Reply Expert Report of Dr. David Schaafsma, PhD Regarding Infringement of U.S. Patent Nos. 10,330,582, 11.703,443, and 12,174,107; (2) Reply Expert Report of Dr. Jessica Houston, PhD Regarding Infringement of U.S. Patent Nos. 10,330,582, 11,703,443, and 12,174,107; (3) Reply Expert Report of Michele M. Riley; and (4) Reply Expert Report of Joseph Paul Robinson filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 02/10/2026)
2026-02-10
1
MOTION for Pro Hac Vice Appearance of Attorney Jennifer Graber - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 02/17/2026)
2026-02-17
1
Pro Hac Vice Fee - Credit Card Payment received for Jennifer Graber. ( re 222 MOTION for Pro Hac Vice Appearance of Attorney Jennifer Graber )( Payment of $ 50, receipt number ADEDC-4901411).(Haynes, Christine) (Entered: 02/17/2026)
2026-02-17
1
MOTION for Hearing to Resolve Discovery Disputes - filed by Cytek Biosciences, Inc.. Motions referred to Eleanor G. Tennyson.(Jacobs, Karen) (Entered: 02/17/2026)
2026-02-17
1
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2026-02-17
1
No Actions
SO ORDERED
2026-02-17
1
No Actions
SO ORDERED, re 222 MOTION for Pro Hac Vice Appearance of Attorney Jennifer Graber, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 2/17/2026. (kmd)
2026-02-17
1
No Actions
Letter to The Honorable Eleanor G. Tennyson from Frederick L. Cottrell, III regarding Cytek's improper filing of a Motion for Hearing to Resolve Discovery Disputes - re 224 MOTION for Hearing to Resolve Discovery Disputes. (Cottrell, Frederick) (Entered: 02/18/2026)
2026-02-18
1
Add Attorneys - PHV only
2026-02-19
1
No Actions
Pro Hac Vice Attorney Jennifer L. Graber for Beckman Coulter, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam)
2026-02-19
1
No Actions
CLAIM CONSTRUCTION ORDER. Signed by Judge Colm F. Connolly on 2/24/2026. (mws) (Entered: 02/24/2026)
2026-02-24
1
ORAL ORDER - IT IS HEREBY ORDERED that, on or before February 26, 2026, Cytek shall file a one-page non-argumentative letter limited to setting forth the timeline of the clawback referenced in its request for a discovery dispute conference (D.I. 224 ). Cytek's letter shall identify the specific clawed back documents objected to, when those documents were clawed back and when the parties had discussions regarding that clawback. ORDERED by Judge Eleanor G. Tennyson on 2/25/2026. (Entered: 02/25/2026)
2026-02-25
1
Oral Order
2026-02-25
1
No Actions
Letter to The Honorable Eleanor G. Tennyson from Jeremy A. Tigan regarding Response to Oral Order - re 227 Oral Order, 224 MOTION for Hearing to Resolve Discovery Disputes. (Tigan, Jeremy) (Entered: 02/26/2026)
2026-02-26
1
Letter to The Honorable Eleanor G. Tennyson from Frederick L. Cottrell, Esq. regarding request for leave to respond to Cyteks timeline. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 02/26/2026)
2026-02-26
1
Letter to The Honorable Eleanor G. Tennyson from Frederick L. Cottrell, Esq. regarding request for leave to respond to Cyteks timeline. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 02/26/2026)
2026-02-26
2
ORAL ORDER re 224 - Fact discovery closed four months ago. Expert discovery just closed. Although a document clawback could in theory provide sufficient justification for raising a discovery dispute after the close of fact discovery, that justification is missing here. Beckman clawed back the documents at issue in November 2025, and Cytek did not act with sufficient diligence over the ensuing months to be able to now seek relief from the Court. (D.I. 288). Cytek simply waited too long under the circumstances. Even if the Court were to consider Beckman's timeline (D.I. 229, Ex. 1), it would only confirm this conclusion. And the other issues raised in Cytek's letter are fact-discovery complaints that should have been raised during fact discovery. (See, e.g., D.I. 93 (seeking documents from Yong Qin Chen in June 2025)). THEREFORE, IT IS HEREBY ORDERED that Cytek's motion for a discovery dispute conference is DENIED. ORDERED by Judge Eleanor G. Tennyson on 2/27/2026. (cdd) (Entered: 02/27/2026)
2026-02-27
1
Oral Order
2026-02-27
1
No Actions
MOTION to Preclude Testimony of Plaintiff's Expert Jessica Houston, Ph.D. regarding Willful Infringement (Motion 1) - filed by Cytek Biosciences, Inc. (Tigan, Jeremy) Modified on 3/13/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
MOTION to Preclude Testimony of Plaintiff's Expert Michael Arnold, Ph.D. regarding Validity (Motion 2) - filed by Cytek Biosciences, Inc. (Tigan, Jeremy) Modified on 3/13/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
[SEALED] OPENING BRIEF in Support re 232 MOTION to Preclude Testimony of Plaintiff's Expert Michael Arnold, Ph.D. regarding Validity (Motion 2), 231 MOTION to Preclude Testimony of Plaintiff's Expert Jessica Houston, Ph.D. regarding Willful Infringement (Motion 1) filed by Cytek Biosciences, Inc..Answering Brief/Response due date per Local Rules is 3/27/2026. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
MOTION for Summary Judgment #1 Against Cytek's "Reverse Doctrine of Equivalents" Defense - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
MOTION for Summary Judgment #1 Against Cytek's "Reverse Doctrine of Equivalents" Defense - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
2
MOTION for Summary Judgment #2 Against Cytek's Failure to Mark Defense - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
MOTION for Summary Judgment #2 Against Cytek's Failure to Mark Defense - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
2
MOTION for Summary Judgment #3 That DXP Cannot Anticipate Claims 11-15 of the '443 Patent - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
MOTION for Summary Judgment #3 That DXP Cannot Anticipate Claims 11-15 of the '443 Patent - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
2
MOTION #1 to Exclude Drs. Ilkov's and Leary's Opinion that Improperly Read Limitations into Claims Should Be Excluded - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
MOTION #1 to Exclude Drs. Ilkov's and Leary's Opinion that Improperly Read Limitations into Claims Should Be Excluded - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #1 to Exclude Drs. Ilkov's and Leary's Opinion that Improperly Read Limitations into Claims Should Be Excluded - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #2 to Exclude Drs. Ilkov's and Leary's Opinions that Contradict the Court's Claim Constructions - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
MOTION #2 to Exclude Drs. Ilkov's and Leary's Opinions that Contradict the Court's Claim Constructions - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #2 to Exclude Drs. Ilkov's and Leary's Opinions that Contradict the Court's Claim Constructions - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #3 to Exclude Drs. Ilkov's and Leary's Opinions on Non-Infringement Based on a Lack of Enablement and Written Description - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
MOTION #3 to Exclude Drs. Ilkov's and Leary's Opinions on Non-Infringement Based on a Lack of Enablement and Written Description - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #3 to Exclude Drs. Ilkov's and Leary's Opinions on Non-Infringement Based on a Lack of Enablement and Written Description - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #4 to Exclude Drs. Ilkov's and Weigl's Improper Claim Construction of "Substantially Full Spectrum of Visible Light" - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
MOTION #4 to Exclude Drs. Ilkov's and Weigl's Improper Claim Construction of "Substantially Full Spectrum of Visible Light" - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #4 to Exclude Drs. Ilkov's and Weigl's Improper Claim Construction of "Substantially Full Spectrum of Visible Light" - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #5 to Exclude Junichiro Kono's Expert Opinions and Dr. Fedor Ilkov's Derivative Opinions Relying on Dr. Kono - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
MOTION #5 to Exclude Junichiro Kono's Expert Opinions and Dr. Fedor Ilkov's Derivative Opinions Relying on Dr. Kono - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #5 to Exclude Junichiro Kono's Expert Opinions and Dr. Fedor Ilkov's Derivative Opinions Relying on Dr. Kono - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #6 to Exclude Mr. Hansen's Adjusted Reasonable Royalty Rate as Based on Unreliable Methodology - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
MOTION #6 to Exclude Mr. Hansen's Adjusted Reasonable Royalty Rate as Based on Unreliable Methodology - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #6 to Exclude Mr. Hansen's Adjusted Reasonable Royalty Rate as Based on Unreliable Methodology - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #7 to Exclude Mr. Hansen's Opinions That Cytek had a Non-Infringing Alternative for "Non-U.S. Sales" - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
1
MOTION #7 to Exclude Mr. Hansen's Opinions That Cytek had a Non-Infringing Alternative for "Non-U.S. Sales" - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION #7 to Exclude Mr. Hansen's Opinions That Cytek had a Non-Infringing Alternative for "Non-U.S. Sales" - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification) (Cottrell, Frederick) Modified on 3/16/2026 (mws). (Entered: 03/13/2026)
2026-03-13
2
MOTION for Summary Judgment of Non-Infringement of Asserted Claims 23 and 26 (Motion 1) - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
MOTION for Summary Judgment of Non-Infringement of Asserted Claims 1, 3 and 6 of the '582 Patent (Motion 2) - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] OPENING BRIEF in Support re 236 MOTION for Summary Judgment #3 That DXP Cannot Anticipate Claims 11-15 of the '443 Patent, 235 MOTION for Summary Judgment #2 Against Cytek's Failure to Mark Defense, 234 MOTION for Summary Judgment #1 Against Cytek's "Reverse Doctrine of Equivalents" Defense filed by Beckman Coulter, Inc..Answering Brief/Response due date per Local Rules is 3/27/2026. (Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
MOTION for Summary Judgment of Invalidity of the Asserted Claims of the '443 and '107 Patents (Motion 3) - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] OPENING BRIEF in Support re 247 MOTION for Summary Judgment of Invalidity of the Asserted Claims of the '443 and '107 Patents (Motion 3), 244 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 23 and 26 (Motion 1), 245 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 1, 3 and 6 of the '582 Patent (Motion 2) filed by Cytek Biosciences, Inc..Answering Brief/Response due date per Local Rules is 3/27/2026. (Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] STATEMENT re 234 MOTION for Summary Judgment #1 Against Cytek's "Reverse Doctrine of Equivalents" Defense [Concise Statement of Facts] by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] STATEMENT re 235 MOTION for Summary Judgment #2 Against Cytek's Failure to Mark Defense [Concise Statement of Facts] by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] STATEMENT re 236 MOTION for Summary Judgment #3 That DXP Cannot Anticipate Claims 11-15 of the '443 Patent [Concise Statement of Facts] by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] OPENING BRIEF in Support re 239 MOTION #3 to Exclude Drs. Ilkov's and Leary's Opinions on Non-Infringement Based on a Lack of Enablement and Written Description, 240 MOTION #4 to Exclude Drs. Ilkov's and Weigl's Improper Claim Construction of "Substantially Full Spectrum of Visible Light", 237 MOTION #1 to Exclude Drs. Ilkov's and Leary's Opinion that Improperly Read Limitations into Claims Should Be Excluded, 238 MOTION #2 to Exclude Drs. Ilkov's and Leary's Opinions that Contradict the Court's Claim Constructions, 241 MOTION #5 to Exclude Junichiro Kono's Expert Opinions and Dr. Fedor Ilkov's Derivative Opinions Relying on Dr. Kono filed by Beckman Coulter, Inc..Answering Brief/Response due date per Local Rules is 3/27/2026. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] OPENING BRIEF in Support re 243 MOTION #7 to Exclude Mr. Hansen's Opinions That Cytek had a Non-Infringing Alternative for "Non-U.S. Sales", 242 MOTION #6 to Exclude Mr. Hansen's Adjusted Reasonable Royalty Rate as Based on Unreliable Methodology filed by Beckman Coulter, Inc..Answering Brief/Response due date per Local Rules is 3/27/2026. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] DECLARATION of Jennifer Graber [Volume 1] re 239 MOTION #3 to Exclude Drs. Ilkov's and Leary's Opinions on Non-Infringement Based on a Lack of Enablement and Written Description, 237 MOTION #1 to Exclude Drs. Ilkov's and Leary's Opinion that Improperly Read Limitations into Claims Should Be Excluded, 238 MOTION #2 to Exclude Drs. Ilkov's and Leary's Opinions that Contradict the Court's Claim Constructions, 242 MOTION #6 to Exclude Mr. Hansen's Adjusted Reasonable Royalty Rate as Based on Unreliable Methodology, 240 MOTION #4 to Exclude Drs. Ilkov's and Weigl's Improper Claim Construction of "Substantially Full Spectrum of Visible Light", 236 MOTION for Summary Judgment #3 That DXP Cannot Anticipate Claims 11-15 of the '443 Patent, 235 MOTION for Summary Judgment #2 Against Cytek's Failure to Mark Defense, 243 MOTION #7 to Exclude Mr. Hansen's Opinions That Cytek had a Non-Infringing Alternative for "Non-U.S. Sales", 241 MOTION #5 to Exclude Junichiro Kono's Expert Opinions and Dr. Fedor Ilkov's Derivative Opinions Relying on Dr. Kono, 234 MOTION for Summary Judgment #1 Against Cytek's "Reverse Doctrine of Equivalents" Defense by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Attachment 11 replaced on 4/29/2026) (mws). (Entered: 03/13/2026)
2026-03-13
1
[SEALED] STATEMENT re 244 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 23 and 26 (Motion 1) by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] EXHIBIT re 254 Declaration,,,,,,, [Jennifer Graber - Volume 2] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26)(Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] DECLARATION of Elizabeth M. Flanagan re 244 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 23 and 26 (Motion 1), 255 Statement by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 1A, # 2 Exhibit 1B, # 3 Exhibit 1C, # 4 Exhibit 1D, # 5 Exhibit 1E, # 6 Exhibit 1F, # 7 Exhibit 1G, # 8 Exhibit 1H, # 9 Exhibit 1I, # 10 Exhibit 1J, # 11 Exhibit 1K, # 12 Exhibit 1L, # 13 Exhibit 1M, # 14 Exhibit 1N)(Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] STATEMENT re 245 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 1, 3 and 6 of the '582 Patent (Motion 2) by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] DECLARATION of Elizabeth M. Flanagan re 258 Statement, 245 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 1, 3 and 6 of the '582 Patent (Motion 2) by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2A, # 2 Exhibit 2B, # 3 Exhibit 2C, # 4 Exhibit 2D, # 5 Exhibit 2E, # 6 Exhibit 2F, # 7 Exhibit 2G, # 8 Exhibit 2H, # 9 Exhibit 2I, # 10 Exhibit 2J, # 11 Exhibit 2K, # 12 Exhibit 2L, # 13 Exhibit 2M, # 14 Exhibit 2N, # 15 Exhibit 2O, # 16 Exhibit 2P)(Tigan, Jeremy) (Attachment 2 replaced on 3/19/2026) (mws). (Attachment 5 replaced on 3/19/2026) (mws). (Attachment 6 replaced on 3/19/2026) (mws). (Attachment 8 replaced on 3/19/2026) (mws). (Attachment 11 replaced on 3/19/2026) (mws). (Attachment 15 replaced on 3/19/2026) (mws). (Entered: 03/13/2026)
2026-03-13
1
[SEALED] STATEMENT re 247 MOTION for Summary Judgment of Invalidity of the Asserted Claims of the '443 and '107 Patents (Motion 3) by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] DECLARATION of Elizabeth M. Flanagan re 247 MOTION for Summary Judgment of Invalidity of the Asserted Claims of the '443 and '107 Patents (Motion 3), 260 Statement by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 3A, # 2 Exhibit 3B, # 3 Exhibit 3C, # 4 Exhibit 3D, # 5 Exhibit 3E, # 6 Exhibit 3F, # 7 Exhibit 3G, # 8 Exhibit 3H, # 9 Exhibit 3I, # 10 Exhibit 3J, # 11 Exhibit 3K, # 12 Exhibit 3L)(Tigan, Jeremy) (Attachment 10 replaced on 3/19/2026) (mws). (Entered: 03/13/2026)
2026-03-13
1
CERTIFICATE OF SERVICE of by Beckman Coulter, Inc. re 256 Exhibit to a Document, 254 Declaration,,,,,,, (Cottrell, Frederick) (Entered: 03/13/2026)
2026-03-13
1
Motions No Longer Referred
2026-03-13
1
No Actions
Motions No Longer Referred: 232 MOTION to Preclude Testimony of Plaintiff's Expert Michael Arnold, Ph.D. regarding Validity (Motion 2), 231 MOTION to Preclude Testimony of Plaintiff's Expert Jessica Houston, Ph.D. regarding Willful Infringement (Motion 1). The automatic referral generated by the system has been removed for these motions. (mws)
2026-03-13
1
No Actions
STIPULATION of Dismissal of Defendant Cytek Biosciences, Inc.'s First Counterclaim Without Prejudice by Beckman Coulter, Inc.. (Farnan, Kelly) (Entered: 03/16/2026)
2026-03-16
1
Motions No Longer Referred
2026-03-16
1
No Actions
Motions No Longer Referred: Plaintiff's Daubert Motions #1-7 (D.I. 237, 238, 239, 240, 241, 242, 243 ). The automatic referrals generated by the system have been removed for these motions. (mws)
2026-03-16
1
No Actions
SO ORDERED, re 263 Stipulation of Dismissal of Defendant Cytek Biosciences, Inc.'s First Counterclaim Without Prejudice, filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 3/17/2026. (kmd) (Entered: 03/17/2026)
2026-03-17
1
Joint MOTION for Hearing to Resolve Discovery Disputes - filed by Cytek Biosciences, Inc.. Motions referred to Eleanor G. Tennyson.(Tigan, Jeremy) (Entered: 03/17/2026)
2026-03-17
1
- CORRECTING ENTRY
2026-03-19
1
No Actions
CORRECTING ENTRY: Exhibits 2B, 2E, 2F, 2H, 2K, and 2O to D.I. 259 and Exhibit 3J to D.I. 261 replaced per counsel request to change black and white images to color. (mws)
2026-03-19
1
No Actions
REDACTED VERSION of 246 Opening Brief in Support,, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 249 Statement, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 250 Statement, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 251 Statement, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 252 Opening Brief in Support,,, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 253 Opening Brief in Support, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 254 Declaration,,,,,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 256 Exhibit to a Document, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26)(Cottrell, Frederick) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 233 Opening Brief in Support,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibits 1-9)(Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 233 Opening Brief in Support,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibits 1-9)(Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
2
REDACTED VERSION of 248 Opening Brief in Support,, by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 255 Statement by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 257 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 1A, # 2 Exhibit 1B, # 3 Exhibit 1C, # 4 Exhibit 1D, # 5 Exhibit 1E, # 6 Exhibit 1F, # 7 Exhibit 1G, # 8 Exhibit 1H, # 9 Exhibit 1I, # 10 Exhibit 1J, # 11 Exhibit 1K, # 12 Exhibit 1L, # 13 Exhibit 1M, # 14 Exhibit 1N)(Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 258 Statement by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 259 Declaration,,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2A, # 2 Exhibit 2B, # 3 Exhibit 2C, # 4 Exhibit 2D, # 5 Exhibit 2E, # 6 Exhibit 2F, # 7 Exhibit 2G, # 8 Exhibit 2H, # 9 Exhibit 2I, # 10 Exhibit 2J, # 11 Exhibit 2K, # 12 Exhibit 2L, # 13 Exhibit 2M, # 14 Exhibit 2N, # 15 Exhibit 2O, # 16 Exhibit 2P)(Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 260 Statement by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 261 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 3A, # 2 Exhibit 3B, # 3 Exhibit 3C, # 4 Exhibit 3D, # 5 Exhibit 3E, # 6 Exhibit 3F, # 7 Exhibit 3G, # 8 Exhibit 3H, # 9 Exhibit 3I, # 10 Exhibit 3J, # 11 Exhibit 3K, # 12 Exhibit 3L)(Clark, Cameron) (Entered: 03/20/2026)
2026-03-20
1
Oral Order AND ~Util - Set Briefing Schedule - open,ans,reply,surreply AND ~Util - Set Hearings
2026-03-20
1
No Actions
ORAL ORDER: The Court's February 26, 2025 oral order referring the case to Magistrate Judge Eleanor G. Tennyson for all matters relating to discovery and the protective order is WITHDRAWN. The joint motion for a hearing to resolve discovery disputes (D.I. 265 ) is GRANTED. The Court will hear oral argument in person in Courtroom 4B on April 16, 2026 at 9:00 a.m. on the matters outlined in the joint motion. As both parties have said they are available on April 16, see D.I. 265 at 3, the Court will not agree to move the April 16 argument, though obviously the Court does not oppose canceling the argument if the parties reach an agreement that resolves all the disputes in question. The movant for any particular issues must file no later than March 26, 2026 a letter in support of its motion for relief for those issues and a proposed order that specifies the exact relief being sought. The respondent shall file no later than April 2, 2026 a letter in response. The letters must be in 14-point font and shall not exceed 1,250 words. The parties should expect that the party that loses a dispute will pay for the costs and fees the winning party incurred in litigating that dispute. The parties should also expect that if the Court decides that a party took an unreasonable position with respect to an issue, the Court will reduce by an appropriate amount the time the Court would have otherwise given that party to try its case. The withdrawal of a request for relief or of an opposition to a request for relief after April 10, 2026 will be treated by the Court as a loss of the dispute over that request. Thus, the parties would be well-advised to meet and confer between April 6 and April 9. Set Hearings: (An Oral Argument is set for 4/16/2026 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly). Ordered by Judge Colm F. Connolly on 3/20/2026. (mws)
2026-03-20
1
No Actions
MOTION to Strike Improper Expert Disclosures - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 03/26/2026)
2026-03-26
1
MOTION to Strike - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification)(Cottrell, Frederick) (Entered: 03/26/2026)
2026-03-26
1
MOTION to Strike - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification)(Cottrell, Frederick) (Entered: 03/26/2026)
2026-03-26
2
MOTION to Strike - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification)(Cottrell, Frederick) (Entered: 03/26/2026)
2026-03-26
2
[SEALED] Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Support of Motion to Strike Improper Expert Disclosures - re 282 MOTION to Strike Improper Expert Disclosures. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Tigan, Jeremy) (Entered: 03/26/2026)
2026-03-26
1
[SEALED] Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding in Support of Beckman Coulter, Inc.'s Motion to Strike - re 283 MOTION to Strike . (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Cottrell, Frederick) (Entered: 03/26/2026)
2026-03-26
1
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
1
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 285 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
2
REDACTED VERSION of 284 Letter, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibits 1-7)(Clark, Cameron) (Entered: 04/02/2026)
2026-04-02
1
REDACTED VERSION of 284 Letter, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibits 1-7)(Clark, Cameron) (Entered: 04/02/2026)
2026-04-02
2
[SEALED] Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Response to Beckman Coulter's Motion to Strike - re 283 MOTION to Strike . (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Tigan, Jeremy) (Entered: 04/02/2026)
2026-04-02
1
[SEALED] Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Opposition to Cytek's Motion to Strike - re 282 MOTION to Strike Improper Expert Disclosures. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/02/2026)
2026-04-02
1
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding withdraw motion to strike - re 283 MOTION to Strike . (Cottrell, Frederick) (Entered: 04/08/2026)
2026-04-08
1
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
1
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 288 Letter,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Clark, Cameron) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
1
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
REDACTED VERSION of 289 Letter,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Cottrell, Frederick) (Entered: 04/09/2026)
2026-04-09
2
[SEALED] ANSWERING BRIEF in Opposition re 236 MOTION for Summary Judgment #3 That DXP Cannot Anticipate Claims 11-15 of the '443 Patent, 235 MOTION for Summary Judgment #2 Against Cytek's Failure to Mark Defense, 234 MOTION for Summary Judgment #1 Against Cytek's "Reverse Doctrine of Equivalents" Defense filed by Cytek Biosciences, Inc..Reply Brief due date per Local Rules is 4/20/2026. (Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] STATEMENT re 249 Statement, /Cytek's Opposition to Plaintiff's Concise Statement of Facts in Support of Summary Judgment Motion #1 by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] DECLARATION of Elizabeth M. Flanagan in Support of Cytek's Opposition to Plaintiff's Concise Statement of Facts in Support of Summary Judgment Motion #1 re 294 Statement by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 1A, # 2 Exhibit 1B, # 3 Exhibit 1C, # 4 Exhibit 1D, # 5 Exhibit 1E, # 6 Exhibit 1F, # 7 Exhibit 1G, # 8 Exhibit 1H, # 9 Exhibit 1I, # 10 Exhibit 1J, # 11 Exhibit 1K, # 12 Exhibit 1L)(Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] STATEMENT re 235 MOTION for Summary Judgment #2 Against Cytek's Failure to Mark Defense, 250 Statement, //Cytek's Opposition to Plaintiff's Concise Statement of Facts in Support of Summary Judgment Motion #2 by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] DECLARATION of Elizabeth M. Flanagan in Support of Cytek's Opposition to Plaintiff's Concise Statement of Facts in Support of Summary Judgment Motion #2 re 296 Statement, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2A, # 2 Exhibit 2B, # 3 Exhibit 2C, # 4 Exhibit 2D, # 5 Exhibit 2E, # 6 Exhibit 2F, # 7 Exhibit 2G, # 8 Exhibit 2H, # 9 Exhibit 21)(Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] STATEMENT re 251 Statement, Cytek's Opposition to Plaintiff's Concise Statement of Facts in Support of Summary Judgment Motion #3 by Cytek Biosciences, Inc.. (Clark, Cameron) Modified on 4/14/2026 (mws). (Entered: 04/13/2026)
2026-04-13
1
[SEALED] DECLARATION of of Elizabeth M. Flanagan in Support of Cytek's Opposition to Plaintiff's Concise Statement of Facts in Support of Summary Judgment Motion #3 re 298 Statement by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 3A, # 2 Exhibit 3B, # 3 Exhibit 3C, # 4 Exhibit 3D, # 5 Exhibit 3E, # 6 Exhibit 3F, # 7 Exhibit 3G, # 8 Exhibit 3H, # 9 Exhibit 3I, # 10 Exhibit 3J, # 11 Exhibit 3K, # 12 Exhibit 3L, # 13 Exhibit 3M, # 14 Exhibit 3N, # 15 Exhibit 3O, # 16 Exhibit 3p)(Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] ANSWERING BRIEF in Opposition re 232 MOTION to Preclude Testimony of Plaintiff's Expert Michael Arnold, Ph.D. regarding Validity (Motion 2), 231 MOTION to Preclude Testimony of Plaintiff's Expert Jessica Houston, Ph.D. regarding Willful Infringement (Motion 1) filed by Beckman Coulter, Inc..Reply Brief due date per Local Rules is 4/20/2026. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] ANSWERING BRIEF in Opposition re 239 MOTION #3 to Exclude Drs. Ilkov's and Leary's Opinions on Non-Infringement Based on a Lack of Enablement and Written Description, 240 MOTION #4 to Exclude Drs. Ilkov's and Weigl's Improper Claim Construction of "Substantially Full Spectrum of Visible Light", 237 MOTION #1 to Exclude Drs. Ilkov's and Leary's Opinion that Improperly Read Limitations into Claims Should Be Excluded, 238 MOTION #2 to Exclude Drs. Ilkov's and Leary's Opinions that Contradict the Court's Claim Constructions, 241 MOTION #5 to Exclude Junichiro Kono's Expert Opinions and Dr. Fedor Ilkov's Derivative Opinions Relying on Dr. Kono filed by Cytek Biosciences, Inc..Reply Brief due date per Local Rules is 4/20/2026. (Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] ANSWERING BRIEF in Opposition re 247 MOTION for Summary Judgment of Invalidity of the Asserted Claims of the '443 and '107 Patents (Motion 3), 244 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 23 and 26 (Motion 1), 245 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 1, 3 and 6 of the '582 Patent (Motion 2) filed by Beckman Coulter, Inc..Reply Brief due date per Local Rules is 4/20/2026. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] STATEMENT re 255 Statement by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] STATEMENT re 258 Statement by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] STATEMENT re 260 Statement by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] DECLARATION of Jennifer Graber re 303 Statement, 305 Statement, 300 Answering Brief in Opposition, 304 Statement by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23)(Cottrell, Frederick) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] DECLARATION of Elizabeth M. Flanagan in Support of Cytek's Oposition to Plaintiff's Daubert Motions #1-5 re 301 Answering Brief in Opposition,,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] ANSWERING BRIEF in Opposition re 243 MOTION #7 to Exclude Mr. Hansen's Opinions That Cytek had a Non-Infringing Alternative for "Non-U.S. Sales", 242 MOTION #6 to Exclude Mr. Hansen's Adjusted Reasonable Royalty Rate as Based on Unreliable Methodology filed by Cytek Biosciences, Inc..Reply Brief due date per Local Rules is 4/20/2026. (Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] DECLARATION of Elizabeth M. Flanagan in Support of Cytek's Oposition to Plaintiff's Daubert Motions # 6-7 re 308 Answering Brief in Opposition, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit AA, # 2 Exhibit BB, # 3 Exhibit CC, # 4 Exhibit DD, # 5 Exhibit EE)(Clark, Cameron) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] DECLARATION of Jennifer Graber [Volume 2] re 300 Answering Brief in Opposition, 304 Statement, 303 Statement, 305 Statement by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 24, # 2 Exhibit 25, # 3 Exhibit 26, # 4 Exhibit 27, # 5 Exhibit 28, # 6 Exhibit 29, # 7 Exhibit 30, # 8 Exhibit 31, # 9 Exhibit 32, # 10 Exhibit 33, # 11 Exhibit 34, # 12 Exhibit 35, # 13 Exhibit 36, # 14 Exhibit 37, # 15 Exhibit 38, # 16 Exhibit 39, # 17 Exhibit 40, # 18 Exhibit 41, # 19 Exhibit 42, # 20 Exhibit 43, # 21 Exhibit 44, # 22 Exhibit 45, # 23 Exhibit 46, # 24 Exhibit 47, # 25 Exhibit 48, # 26 Exhibit 49, # 27 Exhibit 50, # 28 Exhibit 51, # 29 Exhibit 52, # 30 Exhibit 53, # 31 Exhibit 54, # 32 Exhibit 55, # 33 Exhibit 56, # 34 Exhibit 57, # 35 Exhibit 58, # 36 Exhibit 59, # 37 Exhibit 60, # 38 Exhibit 61, # 39 Exhibit 62, # 40 Exhibit 63, # 41 Exhibit 64, # 42 Exhibit 65, # 43 Exhibit 66, # 44 Exhibit 67, # 45 Exhibit 68, # 46 Exhibit 69, # 47 Exhibit 70, # 48 Exhibit 71, # 49 Exhibit 72, # 50 Exhibit 73, # 51 Exhibit 74, # 52 Exhibit 75, # 53 Exhibit 76, # 54 Exhibit 77, # 55 Exhibit 78)(Cottrell, Frederick) (Entered: 04/13/2026)
2026-04-13
1
[SEALED] DECLARATION of Jennifer Graber [Volume 3] re 303 Statement, 305 Statement, 300 Answering Brief in Opposition, 304 Statement by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 79, # 2 Exhibit 80, # 3 Exhibit 81, # 4 Exhibit 82, # 5 Exhibit 83, # 6 Exhibit 84, # 7 Exhibit 85, # 8 Exhibit 86, # 9 Exhibit 87, # 10 Exhibit 88, # 11 Exhibit 89)(Cottrell, Frederick) (Entered: 04/13/2026)
2026-04-13
1
CORRECTING ENTRY: Docket text of D.I. 298 modified per counsel request to correct typo. (mws)
2026-04-14
1
No Actions
- CORRECTING ENTRY
2026-04-14
1
No Actions
NOTICE of Subsequent Authority by Cytek Biosciences, Inc. re 284 Letter, 282 MOTION to Strike Improper Expert Disclosures (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 04/15/2026)
2026-04-15
1
NOTICE of Subsequent Authority by Cytek Biosciences, Inc. re 284 Letter, 282 MOTION to Strike Improper Expert Disclosures (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 04/15/2026)
2026-04-15
2
STIPULATION TO EXTEND TIME and [Proposed] Order to file redacted versions of D.I. 293-311 to May 4, 2026 - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 04/15/2026)
2026-04-15
1
SO ORDERED, re 313 STIPULATION TO EXTEND TIME and [Proposed] Order to file redacted versions of D.I. 293-311 to May 4, 2026, filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 4/16/2026. (kmd) (Entered: 04/16/2026)
2026-04-16
1
Minute Entry for proceedings held before Judge Colm F. Connolly - Oral Argument held on 4/16/2026 re 282 MOTION to Strike Improper Expert Disclosures filed by Cytek Biosciences, Inc. (Court Reporter Bonnie Archer). (mws)
2026-04-16
1
No Actions
ORAL ORDER: Cytek's Motion to Strike Improper Expert Disclosures (D.I. 282 ) is DENIED for the reasons stated on the record at the Oral Argument held today. Ordered by Judge Colm F. Connolly on 4/16/2026. (mws)
2026-04-16
1
No Actions
Oral Argument
2026-04-16
1
No Actions
Oral Order
2026-04-16
1
No Actions
Official Transcript of Discovery Conference / Oral Argument held on 4/16/2026 before Judge Colm F. Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/11/2026. Redacted Transcript Deadline set for 5/21/2026. Release of Transcript Restriction set for 7/20/2026. (mws) (Entered: 04/20/2026)
2026-04-20
1
[SEALED] REPLY BRIEF re 247 MOTION for Summary Judgment of Invalidity of the Asserted Claims of the '443 and '107 Patents (Motion 3), 244 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 23 and 26 (Motion 1), 245 MOTION for Summary Judgment of Non-Infringement of Asserted Claims 1, 3 and 6 of the '582 Patent (Motion 2) filed by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] STATEMENT re 303 Statement /Cytek's Response to "Additional Disputed Facts" Included in BEC's Response to Cytek's Concise Statement of Facts in Support of Cytek's MSJ No. 1 by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] DECLARATION of Elizabeth M. Flanagan In Support of Cytek's Reply Brief In Support of Its MSJ No. 1 re 316 Reply Brief, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 1O)(Clark, Cameron) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] STATEMENT re 304 Statement /Cytek's Response to "Additional Disputed Facts" Included in BEC's Response to Cytek's Concise Statement of Facts in Support of Cytek's MSJ No. 2 by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] DECLARATION of Elizabeth M. Flanagan in Support of Cytek's Reply Brief in Support of Its MSJ No. 2 re 316 Reply Brief, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2Q, # 2 Exhibit 2R, # 3 Exhibit 2S, # 4 Exhibit 2T)(Clark, Cameron) Modified on 4/30/2026 (mws). (Entered: 04/29/2026)
2026-04-29
1
[SEALED] STATEMENT re 305 Statement /Cytek's Response to "Additional Disputed Facts" Included in BEC's Response to Cytek's Concise Statement of Facts in Support of Cytek's MSJ No. 3 by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] DECLARATION of Elizabeth M. Flanagan in Support of Cytek's Reply Brief in Support of Its MSJ No. 3 re 316 Reply Brief, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 3M, # 2 Exhibit 3N)(Clark, Cameron) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] REPLY BRIEF re 232 MOTION to Preclude Testimony of Plaintiff's Expert Michael Arnold, Ph.D. regarding Validity (Motion 2), 231 MOTION to Preclude Testimony of Plaintiff's Expert Jessica Houston, Ph.D. regarding Willful Infringement (Motion 1) filed by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] DECLARATION of Elizabeth M. Flanagan in Support of Cytek's Reply Brief Regarding Its Daubert Motions 1-2 re 323 Reply Brief, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11, # 3 Exhibit 12, # 4 Exhibit 13, # 5 Exhibit 14)(Clark, Cameron) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] REPLY BRIEF re 243 MOTION #7 to Exclude Mr. Hansen's Opinions That Cytek had a Non-Infringing Alternative for "Non-U.S. Sales", 242 MOTION #6 to Exclude Mr. Hansen's Adjusted Reasonable Royalty Rate as Based on Unreliable Methodology filed by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] REPLY BRIEF re 236 MOTION for Summary Judgment #3 That DXP Cannot Anticipate Claims 11-15 of the '443 Patent, 235 MOTION for Summary Judgment #2 Against Cytek's Failure to Mark Defense, 234 MOTION for Summary Judgment #1 Against Cytek's "Reverse Doctrine of Equivalents" Defense filed by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] REPLY BRIEF re 239 MOTION #3 to Exclude Drs. Ilkov's and Leary's Opinions on Non-Infringement Based on a Lack of Enablement and Written Description, 240 MOTION #4 to Exclude Drs. Ilkov's and Weigl's Improper Claim Construction of "Substantially Full Spectrum of Visible Light", 237 MOTION #1 to Exclude Drs. Ilkov's and Leary's Opinion that Improperly Read Limitations into Claims Should Be Excluded, 238 MOTION #2 to Exclude Drs. Ilkov's and Leary's Opinions that Contradict the Court's Claim Constructions, 241 MOTION #5 to Exclude Junichiro Kono's Expert Opinions and Dr. Fedor Ilkov's Derivative Opinions Relying on Dr. Kono filed by Beckman Coulter, Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 04/29/2026)
2026-04-29
1
[SEALED] DECLARATION of Jennifer Graber re 325 Reply Brief, 326 Reply Brief, 327 Reply Brief,,, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 04/29/2026)
2026-04-29
1
CORRECTING ENTRY: Exhibit 11 to D.I. 254 replaced per request of counsel to correct highlighting. (mws)
2026-04-29
1
No Actions
- CORRECTING ENTRY
2026-04-29
1
No Actions
REDACTED VERSION of 300 Answering Brief in Opposition, to Motion to Preclude Expert Testimony Nos. 1& 2 by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 302 Answering Brief in Opposition,, to Motion for Summary Judgment No. 1-3 by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 303 Statement by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 304 Statement by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 305 Statement by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 306 Declaration,, Of Jennifer Graber by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23)(Haynes, Christine) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 310 Declaration,,,,, Jennifer Graber [Volume 2] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 24, # 2 Exhibit 25, # 3 Exhibit 26, # 4 Exhibit 27, # 5 Exhibit 28, # 6 Exhibit 29, # 7 Exhibit 30, # 8 Exhibit 31, # 9 Exhibit 32, # 10 Exhibit 33, # 11 Exhibit 34, # 12 Exhibit 35, # 13 Exhibit 36, # 14 Exhibit 37, # 15 Exhibit 38, # 16 Exhibit 39, # 17 Exhibit 40, # 18 Exhibit 41, # 19 Exhibit 42, # 20 Exhibit 43, # 21 Exhibit 44, # 22 Exhibit 45, # 23 Exhibit 46, # 24 Exhibit 47, # 25 Exhibit 48, # 26 Exhibit 49, # 27 Exhibit 50, # 28 Exhibit 51, # 29 Exhibit 52, # 30 Exhibit 53, # 31 Exhibit 54, # 32 Exhibit 55, # 33 Exhibit 56, # 34 Exhibit 57, # 35 Exhibit 58, # 36 Exhibit 59, # 37 Exhibit 60, # 38 Exhibit 61, # 39 Exhibit 62, # 40 Exhibit 63, # 41 Exhibit 64, # 42 Exhibit 65, # 43 Exhibit 66, # 44 Exhibit 67, # 45 Exhibit 68, # 46 Exhibit 69, # 47 Exhibit 70, # 48 Exhibit 71, # 49 Exhibit 72, # 50 Exhibit 73, # 51 Exhibit 74, # 52 Exhibit 75, # 53 Exhibit 76, # 54 Exhibit 77, # 55 Exhibit 78)(Haynes, Christine) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 311 Declaration, of Jennifer Graber [Volume 3] by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 79, # 2 Exhibit 80, # 3 Exhibit 81, # 4 Exhibit 82, # 5 Exhibit 83, # 6 Exhibit 84, # 7 Exhibit 85, # 8 Exhibit 86, # 9 Exhibit 87, # 10 Exhibit 88, # 11 Exhibit 89)(Haynes, Christine) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 293 Answering Brief in Opposition, to Motions for Summary Judgment 1-3 by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 294 Statement by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 295 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 1A, # 2 Exhibit 1B, # 3 Exhibit 1C, # 4 Exhibit 1D, # 5 Exhibit 1E, # 6 Exhibit 1F, # 7 Exhibit 1G, # 8 Exhibit 1H, # 9 Exhibit 1I, # 10 Exhibit 1J, # 11 Exhibit 1K, # 12 Exhibit 1L)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 296 Statement, by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 297 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2A, # 2 Exhibit 2B, # 3 Exhibit 2C, # 4 Exhibit 2D, # 5 Exhibit 2E, # 6 Exhibit 2F, # 7 Exhibit 2G, # 8 Exhibit 2H, # 9 Exhibit 2I)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 298 Statement by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 299 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 3A, # 2 Exhibit 3B, # 3 Exhibit 3C, # 4 Exhibit 3D, # 5 Exhibit 3E, # 6 Exhibit 3F, # 7 Exhibit 3G, # 8 Exhibit 3H, # 9 Exhibit 3I, # 10 Exhibit 3J, # 11 Exhibit 3K, # 12 Exhibit 3L, # 13 Exhibit 3M, # 14 Exhibit 3N, # 15 Exhibit 3O, # 16 Exhibit 3P)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 301 Answering Brief in Opposition,,, by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 307 Declaration,, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, Part 1, # 23 Exhibit V, Part 2, # 24 Exhibit W)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
2
REDACTED VERSION of 308 Answering Brief in Opposition, by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 309 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit AA, # 2 Exhibit BB, # 3 Exhibit CC, # 4 Exhibit DD, # 5 Exhibit EE)(Clark, Cameron) (Entered: 05/04/2026)
2026-05-04
1
REDACTED VERSION of 316 Reply Brief, by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 317 Statement, by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 318 Declaration by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 1O)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 319 Statement, by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 320 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2Q, # 2 Exhibit 2R, # 3 Exhibit 2S, # 4 Exhibit 2T)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 320 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2Q, # 2 Exhibit 2R, # 3 Exhibit 2S, # 4 Exhibit 2T)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 320 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2Q, # 2 Exhibit 2R, # 3 Exhibit 2S, # 4 Exhibit 2T)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 320 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2Q, # 2 Exhibit 2R, # 3 Exhibit 2S, # 4 Exhibit 2T)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 320 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 2Q, # 2 Exhibit 2R, # 3 Exhibit 2S, # 4 Exhibit 2T)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 321 Statement, by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 322 Declaration by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 3M, # 2 Exhibit 3N)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 323 Reply Brief, by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 324 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11, # 3 Exhibit 12, # 4 Exhibit 13, # 5 Exhibit 14)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 324 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11, # 3 Exhibit 12, # 4 Exhibit 13, # 5 Exhibit 14)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 324 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11, # 3 Exhibit 12, # 4 Exhibit 13, # 5 Exhibit 14)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 324 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11, # 3 Exhibit 12, # 4 Exhibit 13, # 5 Exhibit 14)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 324 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11, # 3 Exhibit 12, # 4 Exhibit 13, # 5 Exhibit 14)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 324 Declaration, by Cytek Biosciences, Inc.. (Attachments: # 1 Exhibit 10, # 2 Exhibit 11, # 3 Exhibit 12, # 4 Exhibit 13, # 5 Exhibit 14)(Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 325 Reply Brief, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 326 Reply Brief, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 327 Reply Brief,,, by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
1
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
REDACTED VERSION of 328 Declaration, by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 10-A, # 2 Exhibit 12-A, # 3 Exhibit 27, # 4 Exhibit 28, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34, # 11 Exhibit 35, # 12 Exhibit 36, # 13 Exhibit 37, # 14 Exhibit 38)(Cottrell, Frederick) (Entered: 05/06/2026)
2026-05-06
2
Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Request for Oral Argument. (Tigan, Jeremy) (Entered: 05/06/2026)
2026-05-06
1
MOTION for Pro Hac Vice Appearance of Attorney Robert J. Gunther, Jr. and James M. Dowd - filed by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 05/11/2026)
2026-05-11
1
Pro Hac Vice Fee - Credit Card Payment received for Robert J. Gunther, Jr. and James M. Dowd. ( re 362 MOTION for Pro Hac Vice Appearance of Attorney Robert J. Gunther, Jr. and James M. Dowd )( Payment of $ 100, receipt number BDEDC-4966702).(Cottrell, Frederick) (Entered: 05/11/2026)
2026-05-11
1
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
2026-05-11
1
No Actions
SO ORDERED, re 362 MOTION for Pro Hac Vice Appearance of Attorney Robert J. Gunther, Jr. and James M. Dowd, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 5/11/2026. (kmd)
2026-05-11
1
No Actions
SO ORDERED
2026-05-11
1
No Actions
Pro Hac Vice Attorney Robert J. Gunther, Jr & James M. Dowd for Beckman Coulter, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk)
2026-05-12
1
No Actions
Add Attorneys - PHV only
2026-05-12
1
No Actions
NOTICE of Supplemental Authority, re 293 ANSWERING BRIEF in Opposition, filed by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Jacobs, Karen) Modified on 6/24/2026 (mws). (Entered: 06/23/2026)
2026-06-23
1
NOTICE of Supplemental Authority, re 293 ANSWERING BRIEF in Opposition, filed by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Jacobs, Karen) Modified on 6/24/2026 (mws). (Entered: 06/23/2026)
2026-06-23
2
NOTICE of Supplemental Authority, re 293 ANSWERING BRIEF in Opposition, filed by Cytek Biosciences, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Jacobs, Karen) Modified on 6/24/2026 (mws). (Entered: 06/23/2026)
2026-06-23
2
ORDER: Defendant's Daubert Motion 1: To Exclude Testimony of Plaintiff's Expert Jessica Houston, Ph.D. Regarding Willful Infringement (D.I. 231 ) is GRANTED. See Order for further details. Signed by Judge Colm F. Connolly on 7/1/2026. (mws) (Entered: 07/01/2026)
2026-07-01
1
ORDER: Defendant's Daubert Motion 2: To Exclude Testimony of Plaintiff's Expert Michael Arnold, Ph.D. Regarding Validity (D.I. 232 ) is GRANTED. See Order for further details. Signed by Judge Colm F. Connolly on 7/1/2026. (mws) (Entered: 07/01/2026)
2026-07-01
1
MEMORANDUM ORDER: Plaintiff Beckman Coulter, Inc.'s Motion for Summary Judgment #1 Against Cytek's "Reverse Doctrine of Equivalents" Defense (D.I. 234 ) is DENIED. Signed by Judge Colm F. Connolly on 7/1/2026. (mws) (Entered: 07/01/2026)
2026-07-01
1
ORDER: It is HEREBY ORDERED that: (1) Plaintiff's Motion for Summary Judgment No. 2 (D.I. 235 ) is DENIED. (2) Plaintiff's Motion for Summary Judgment No. 3 (D.I. 236 ) is DENIED. Signed by Judge Colm F. Connolly on 7/2/2026. (mws) (Entered: 07/02/2026)
2026-07-02
1
NOTICE OF SERVICE of Defendant Cytek Biosciences, Inc.'s Fourth Amended Rule 26(a)(1) Initial Disclosures filed by Cytek Biosciences, Inc..(Tigan, Jeremy) (Entered: 07/07/2026)
2026-07-07
1
NOTICE to Take Deposition of Laurent Ginestet Araki on July 14, 2026 filed by Beckman Coulter, Inc..(Haynes, Christine) (Entered: 07/07/2026)
2026-07-07
1
Proposed Voir Dire by Beckman Coulter, Inc.. (Cottrell, Frederick) (Main Document 371 replaced on 8/3/2026) (mws). Modified on 8/3/2026 (mws). (Entered: 07/17/2026)
2026-07-17
1
VERDICT SHEET by Beckman Coulter, Inc. (Plaintiff's Proposed Phase I and Phase II Verdict Sheets). (Cottrell, Frederick) (Main Document 372 replaced on 8/3/2026) (mws). Modified on 8/3/2026 (mws). (Entered: 07/17/2026)
2026-07-17
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint Proposed Preliminary Jury Instructions (Phase I). (Cottrell, Frederick) (Main Document 373 replaced on 8/3/2026) (mws). Modified on 8/3/2026 (mws). (Entered: 07/17/2026)
2026-07-17
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint Proposed Preliminary Jury Instructions (Phase II). (Cottrell, Frederick) (Main Document 374 replaced on 8/3/2026) (mws). Modified on 8/3/2026 (mws). (Entered: 07/17/2026)
2026-07-17
1
VERDICT SHEET by Cytek Biosciences, Inc. (Defendant's Proposed Phase I and Phase II Verdict Sheets). (Clark, Cameron) (Entered: 07/17/2026)
2026-07-17
1
[SEALED] Proposed Pretrial Order Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Main Document 376 replaced on 7/24/2026) (mws). (Entered: 07/17/2026)
2026-07-17
1
Proposed Pretrial Order Volume II by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11)(Cottrell, Frederick) (Main Document 377 replaced on 8/3/2026) (mws). (Attachment 1 replaced on 8/3/2026) (mws). Modified on 8/3/2026 (mws). (Entered: 07/17/2026)
2026-07-17
1
Proposed Pretrial Order Volume III by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 12)(Cottrell, Frederick) (Main Document 378 replaced on 8/3/2026) (mws). (Attachment 1 replaced on 8/3/2026) (mws). Modified on 8/3/2026 (mws). (Entered: 07/17/2026)
2026-07-17
1
[SEALED] Proposed Pretrial Order Volume IV by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Attachment 5 replaced on 7/22/2026) (mws). (Entered: 07/17/2026)
2026-07-17
1
[SEALED] Proposed Pretrial Order Volume V by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 07/17/2026)
2026-07-17
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint Proposed Final Jury Instructions (Phase I). (Cottrell, Frederick) (Main Document 381 replaced on 8/3/2026) (mws). Modified on 8/3/2026 (mws). (Entered: 07/17/2026)
2026-07-17
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint Proposed Final Jury Instructions (Phase II). (Cottrell, Frederick) (Main Document 382 replaced on 8/3/2026) (mws). Modified on 8/3/2026 (mws). (Entered: 07/17/2026)
2026-07-17
1
- CORRECTING ENTRY
2026-07-22
1
No Actions
CORRECTING ENTRY: PDF of Exhibit 17 to the Pretrial Order (D.I. 379-5) replaced as the original filing included the incorrect reply brief. (mws)
2026-07-22
1
No Actions
ORDER: The Court will stand down on its review of Beckman Coulter's seven Daubert motions until the Court receives from the lead counsel of the two firms that represent Beckman Coulter in this matter certifications that (1) confirm that they have read all the briefs filed in support of Beckman Coulter's seven Daubert motions, (2) identify any erroneous quotations or citations, and (3) confirm the accuracy of all other quotations and citations. Signed by Judge Colm F. Connolly on 7/23/2026. (mws) (Entered: 07/23/2026)
2026-07-23
1
MEMORANDUM ORDER: Cytek's Motion for Summary Judgment No. 1 (D.I. 244 ) is DENIED. Signed by Judge Colm F. Connolly on 7/23/2026. (mws) (Entered: 07/23/2026)
2026-07-23
1
ORDER: Cytek's Motion for Summary Judgment No. 2 (D.I. 245 ) and Motion for Summary Judgment No. 3 (D.I. 247 ) are DENIED. Signed by Judge Colm F. Connolly on 7/24/2026. (mws) (Entered: 07/24/2026)
2026-07-24
1
MOTION for Pro Hac Vice Appearance of Attorney Gillian T. Farrell and Daniel S. Perry - filed by Beckman Coulter, Inc.. (Farnan, Kelly) (Entered: 07/24/2026)
2026-07-24
1
Pro Hac Vice Fee - Credit Card Payment received for Gillian T. Farrell and Daniel S. Perry. ( re 386 MOTION for Pro Hac Vice Appearance of Attorney Gillian T. Farrell and Daniel S. Perry )( Payment of $ 100, receipt number ADEDC-5024293).(Farnan, Kelly) (Entered: 07/24/2026)
2026-07-24
1
ORDER: Counsel for Beckman Coulter shall show no later than July 30, 2026 good cause why they should not be sanctioned for the repeated filing without justification of pleadings under seal. Set Deadlines: Show Cause Response due by 7/30/2026. Signed by Judge Colm F. Connolly on 7/24/2026. (mws) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 371 Proposed Voir Dire by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 372 Verdict Sheet by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 373 Proposed Jury Instructions by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 374 Proposed Jury Instructions by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 377 Proposed Pretrial Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 377 Proposed Pretrial Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 381 Proposed Jury Instructions by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 382 Proposed Jury Instructions by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 378 Proposed Pretrial Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 12)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 378 Proposed Pretrial Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 12)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 376 Proposed Pretrial Order, Volume I by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 380 Proposed Pretrial Order Volume V by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
1
REDACTED VERSION of 380 Proposed Pretrial Order Volume V by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 380 Proposed Pretrial Order Volume V by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 380 Proposed Pretrial Order Volume V by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
REDACTED VERSION of 380 Proposed Pretrial Order Volume V by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 07/24/2026)
2026-07-24
2
- CORRECTING ENTRY
2026-07-24
1
No Actions
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
2026-07-24
1
No Actions
SO ORDERED
2026-07-24
1
No Actions
CORRECTING ENTRY: PDF of Volume I of the Proposed Pretrial Order (D.I. 376) replaced per Counsel request to include missing footnote and update footnote numbering. (mws)
2026-07-24
1
No Actions
SO ORDERED, re 386 MOTION for Pro Hac Vice Appearance of Attorney Gillian T. Farrell and Daniel S. Perry, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 7/24/2026. (kmd)
2026-07-24
1
No Actions
Letter to The Honorable Colm F. Connolly from Lead Counsel for Beckman Coulter, Inc. regarding citation corrections. (Attachments: # 1 Attachment A, # 2 Attachment C, # 3 Attachment G, # 4 Attachment J)(Cottrell, Frederick) (Entered: 07/28/2026)
2026-07-28
1
Letter to The Honorable Colm F. Connolly from Lead Counsel for Beckman Coulter, Inc. regarding citation corrections. (Attachments: # 1 Attachment A, # 2 Attachment C, # 3 Attachment G, # 4 Attachment J)(Cottrell, Frederick) (Entered: 07/28/2026)
2026-07-28
2
Letter to The Honorable Colm F. Connolly from Lead Counsel for Beckman Coulter, Inc. regarding citation corrections. (Attachments: # 1 Attachment A, # 2 Attachment C, # 3 Attachment G, # 4 Attachment J)(Cottrell, Frederick) (Entered: 07/28/2026)
2026-07-28
2
Letter to The Honorable Colm F. Connolly from Lead Counsel for Beckman Coulter, Inc. regarding citation corrections. (Attachments: # 1 Attachment A, # 2 Attachment C, # 3 Attachment G, # 4 Attachment J)(Cottrell, Frederick) (Entered: 07/28/2026)
2026-07-28
2
Letter to The Honorable Colm F. Connolly from Lead Counsel for Beckman Coulter, Inc. regarding citation corrections. (Attachments: # 1 Attachment A, # 2 Attachment C, # 3 Attachment G, # 4 Attachment J)(Cottrell, Frederick) (Entered: 07/28/2026)
2026-07-28
2
[SEALED] EXHIBIT re 400 Letter Attachments B, D, E, F, H, and I by Beckman Coulter, Inc.. (Attachments: # 1 Attachment B, # 2 Attachment D, # 3 Attachment E, # 4 Attachment F, # 5 Attachment H, # 6 Attachment I)(Cottrell, Frederick) (Entered: 07/28/2026)
2026-07-28
1
RESPONSE to Order re 388 Order to Show Cause, filed by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
1
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
1
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
DECLARATION of Robert J. Gunther, Jr. re 402 Response to Order by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22)(Cottrell, Frederick) (Entered: 07/30/2026)
2026-07-30
2
ORDER: Beckman's Daubert Motion #6 to Exclude Mr. Hansen's Adjusted Reasonable Royalty Rate as Based on Unreliable Methodology (D.I. 242 ) is DENIED. Signed by Judge Colm F. Connolly on 8/3/2026. (mws) (Entered: 08/03/2026)
2026-08-03
1
NOTICE of Appearance by Gabriela Monasterio on behalf of Beckman Coulter, Inc. (Monasterio, Gabriela) (Entered: 08/03/2026)
2026-08-03
1
CORRECTING ENTRY: Docket entries 371, 372, 373, 374, 377, 378, 381, and 382 have been unsealed per request of Counsel for Beckman Coulter, Inc. (mws)
2026-08-03
1
No Actions
- CORRECTING ENTRY
2026-08-03
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Thomas G. Saunders and Patrick Nyman, PhD - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 08/04/2026)
2026-08-04
1
Pro Hac Vice Fee - Credit Card Payment received for Thomas G. Saunders and Patrick Nyman, PhD. ( re 406 MOTION for Pro Hac Vice Appearance of Attorney Thomas G. Saunders and Patrick Nyman, PhD )( Payment of $ 100, receipt number ADEDC-5033221).(Haynes, Christine) (Entered: 08/04/2026)
2026-08-04
1
MOTION Exemption of Persons from the District of Delawares May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Haynes, Christine) (Entered: 08/04/2026)
2026-08-04
1
MOTION Exemption of Persons from the District of Delawares May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Haynes, Christine) (Entered: 08/04/2026)
2026-08-04
2
REDACTED VERSION of 401 Exhibit to a Document, Letter Attachments B, D, E, F, H and I by Beckman Coulter, Inc.. (Attachments: # 1 B, # 2 D, # 3 E, # 4 F, # 5 H, # 6 I)(Cottrell, Frederick) (Entered: 08/04/2026)
2026-08-04
1
REDACTED VERSION of 401 Exhibit to a Document, Letter Attachments B, D, E, F, H and I by Beckman Coulter, Inc.. (Attachments: # 1 B, # 2 D, # 3 E, # 4 F, # 5 H, # 6 I)(Cottrell, Frederick) (Entered: 08/04/2026)
2026-08-04
2
REDACTED VERSION of 401 Exhibit to a Document, Letter Attachments B, D, E, F, H and I by Beckman Coulter, Inc.. (Attachments: # 1 B, # 2 D, # 3 E, # 4 F, # 5 H, # 6 I)(Cottrell, Frederick) (Entered: 08/04/2026)
2026-08-04
2
REDACTED VERSION of 401 Exhibit to a Document, Letter Attachments B, D, E, F, H and I by Beckman Coulter, Inc.. (Attachments: # 1 B, # 2 D, # 3 E, # 4 F, # 5 H, # 6 I)(Cottrell, Frederick) (Entered: 08/04/2026)
2026-08-04
2
REDACTED VERSION of 401 Exhibit to a Document, Letter Attachments B, D, E, F, H and I by Beckman Coulter, Inc.. (Attachments: # 1 B, # 2 D, # 3 E, # 4 F, # 5 H, # 6 I)(Cottrell, Frederick) (Entered: 08/04/2026)
2026-08-04
2
REDACTED VERSION of 401 Exhibit to a Document, Letter Attachments B, D, E, F, H and I by Beckman Coulter, Inc.. (Attachments: # 1 B, # 2 D, # 3 E, # 4 F, # 5 H, # 6 I)(Cottrell, Frederick) (Entered: 08/04/2026)
2026-08-04
2
REDACTED VERSION of 401 Exhibit to a Document, Letter Attachments B, D, E, F, H and I by Beckman Coulter, Inc.. (Attachments: # 1 B, # 2 D, # 3 E, # 4 F, # 5 H, # 6 I)(Cottrell, Frederick) (Entered: 08/04/2026)
2026-08-04
2
ORAL ORDER: On or before August 10, 2026, the parties shall jointly submit a glossary of terms and names for the court reporter. Ordered by Judge Colm F. Connolly on 8/4/2026. (mws)
2026-08-04
1
No Actions
SO ORDERED, re 406 MOTION for Pro Hac Vice Appearance of Attorney Thomas G. Saunders and Patrick Nyman, PhD, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 8/4/2026. (kmd)
2026-08-04
1
No Actions
Oral Order
2026-08-04
1
No Actions
SO ORDERED
2026-08-04
1
No Actions
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
2026-08-04
1
No Actions
ORDER granting 408 MOTION Exemption of Persons from the District of Delawares May 17, 2024 Standing Order on Personal Devices. Signed by Judge Colm F. Connolly on 8/5/2026. (kmd) (Entered: 08/05/2026)
2026-08-05
1
NOTICE of Withdrawal of Counsel by Cytek Biosciences, Inc. (Clark, Cameron) (Entered: 08/05/2026)
2026-08-05
1
MOTION for Pro Hac Vice Appearance of Attorney Lauren Strosnick and Joseph Van Tassel - filed by Cytek Biosciences, Inc.. (Clark, Cameron) (Entered: 08/05/2026)
2026-08-05
1
Pro Hac Vice Fee - Credit Card Payment received for Lauren Strosnick and Joseph Van Tassel. ( re 412 MOTION for Pro Hac Vice Appearance of Attorney Lauren Strosnick and Joseph Van Tassel )( Payment of $ 100, receipt number ADEDC-5034140).(Clark, Cameron) (Entered: 08/05/2026)
2026-08-05
1
DEPOSITION DESIGNATIONS filed by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11-A, # 2 Exhibit 11-B, # 3 Exhibit 12-A, # 4 Exhibit 12-B, # 5 Objection Keys)(Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
1
DEPOSITION DESIGNATIONS filed by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11-A, # 2 Exhibit 11-B, # 3 Exhibit 12-A, # 4 Exhibit 12-B, # 5 Objection Keys)(Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
2
DEPOSITION DESIGNATIONS filed by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11-A, # 2 Exhibit 11-B, # 3 Exhibit 12-A, # 4 Exhibit 12-B, # 5 Objection Keys)(Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
2
DEPOSITION DESIGNATIONS filed by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11-A, # 2 Exhibit 11-B, # 3 Exhibit 12-A, # 4 Exhibit 12-B, # 5 Objection Keys)(Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
2
DEPOSITION DESIGNATIONS filed by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11-A, # 2 Exhibit 11-B, # 3 Exhibit 12-A, # 4 Exhibit 12-B, # 5 Objection Keys)(Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
2
DEPOSITION DESIGNATIONS filed by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 11-A, # 2 Exhibit 11-B, # 3 Exhibit 12-A, # 4 Exhibit 12-B, # 5 Objection Keys)(Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
2
Joint STIPULATION and Order Dismissing Claims Regarding U.S. Patent No. 12,174,106 - filed by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint Proposed Preliminary Jury Instructions (Phase I). (Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
1
Proposed Jury Instructions by Beckman Coulter, Inc. Corrected Joint [Proposed] Final Jury Instructions (Phase II). (Attachments: # 1 Redline)(Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
1
Proposed Jury Instructions by Beckman Coulter, Inc. Corrected Joint [Proposed] Final Jury Instructions (Phase II). (Attachments: # 1 Redline)(Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
2
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Resolution of PTO Disputes. (Cottrell, Frederick) (Entered: 08/05/2026)
2026-08-05
1
SO ORDERED, re 412 MOTION for Pro Hac Vice Appearance of Attorney Lauren Strosnick and Joseph Van Tassel, filed by Cytek Biosciences, Inc. Ordered by Judge Colm F. Connolly on 8/5/2026. (kmd)
2026-08-05
1
No Actions
Pro Hac Vice Attorney Lauren Strosnick, Joseph E. Van Tassel for Cytek Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)
2026-08-05
1
No Actions
SO ORDERED
2026-08-05
1
No Actions
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
2026-08-05
1
No Actions
Add Attorneys - PHV only
2026-08-05
1
No Actions
SO ORDERED, re 415 Joint STIPULATION and Order Dismissing Claims Regarding U.S. Patent No. 12,174,106, filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 8/6/2026. (kmd) (Entered: 08/06/2026)
2026-08-06
1
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
1
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
REDACTED VERSION of 379 Proposed Pretrial Order Volume IV (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 13, # 2 Exhibit 14, # 3 Exhibit 15, # 4 Exhibit 16, # 5 Exhibit 17)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
REDACTED VERSION of 380 Proposed Pretrial Order Volume V (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
1
REDACTED VERSION of 380 Proposed Pretrial Order Volume V (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
REDACTED VERSION of 380 Proposed Pretrial Order Volume V (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
REDACTED VERSION of 380 Proposed Pretrial Order Volume V (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
REDACTED VERSION of 380 Proposed Pretrial Order Volume V (Updated) by Beckman Coulter, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21)(Cottrell, Frederick) (Entered: 08/06/2026)
2026-08-06
2
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding resolved issues for pre-trial conference. (Cottrell, Frederick) (Entered: 08/07/2026)
2026-08-07
1
STIPULATION Regarding Authenticity and Admissibility of Documents Under Fed.R.Evid. 902(11) and 803(6) - filed by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 08/07/2026)
2026-08-07
1
STIPULATION to Amend Deadline to Submit Joint Exhibit List - filed by Beckman Coulter, Inc.. (Haynes, Christine) (Entered: 08/07/2026)
2026-08-07
1
Official Transcript of Pretrial Conference held on 8/7/2026 before Judge Colm F. Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/31/2026. Redacted Transcript Deadline set for 9/10/2026. Release of Transcript Restriction set for 11/9/2026. (mws) (Entered: 08/10/2026)
2026-08-10
1
SO ORDERED, re 423 STIPULATION Regarding Authenticity and Admissibility of Documents Under Fed.R.Evid. 902(11) and 803(6) filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 8/10/2026. (mws) (Entered: 08/10/2026)
2026-08-10
1
SO ORDERED, re 424 STIPULATION to Amend Deadline to Submit Joint Exhibit List filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 8/10/2026. (mws) (Entered: 08/10/2026)
2026-08-10
1
STATEMENT re Oral Order - Glossary of Terms and Names by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 08/10/2026)
2026-08-10
1
Oral Order
2026-08-10
1
No Actions
Pretrial Conference - Final
2026-08-10
1
No Actions
Minute Entry for proceedings held before Judge Colm F. Connolly: Final Pretrial Conference held on 8/10/2026. (Court Reporter Bonnie Archer). (mws)
2026-08-10
1
No Actions
ORAL ORDER: The Proposed Pretrial Order (D.I.376, 377, 378, 379, 380) is ADOPTED as modified by the discussion and the Court's rulings at the Pretrial Conference. Ordered by Judge Colm F. Connolly on 8/10/2026. (mws)
2026-08-10
1
No Actions
ORAL ORDER: For the reasons stated on the record at the pretrial conference, it is HEREBY ORDERED that: (1) Plaintiff Beckman Coulter, Inc.'s Motion #1 to Exclude Drs. Ilkov's and Leary's Opinions that Improperly Read Limitations Into Claims Should Be Excluded (D.I. 237 ) is DENIED; (2) Plaintiff Beckman Coulter, Inc.'s Motion #2 to Exclude Drs. Ilkov's and Leary's Opinions that Contradict the Court's Claim Constructions (D.I. 238 ) is GRANTED IN PART and DENIED IN PART; (3) Plaintiff Beckman Coulter, Inc.'s Motion #3 to Exclude Drs. Ilkov's and Leary's Opinions on Non-Infringement Based on a Lack of Enablement and Written Description (D.I. 239 ) is DENIED; (4) Plaintiff Beckman Coulter, Inc.'s Motion #4 to Exclude Drs. Ilkov's and Weigl's Improper Claim Construction of "Substantially Full Spectrum of Visible Light" (D.I. 240 ) is DENIED AS MOOT; (5) Plaintiff Beckman Coulter, Inc.'s Motion #5 to Exclude Junichiro Kono's Expert Opinions and Dr. Fedor Ilkov's Derivative Opinions Relying on Dr. Kono (D.I. 241 ) is DENIED AS MOOT; (6) Plaintiff Beckman Coulter, Inc.'s Motion #7 to Exclude Mr. Hansen's Opinions That Cytek had a Non-Infringing Alternative for "Non-U.S. Sales" (D.I. 243 ) is DENIED. Ordered by Judge Colm F. Connolly on 8/10/2026. (mws)
2026-08-10
1
No Actions
MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 08/11/2026)
2026-08-11
1
Oral Order
2026-08-11
1
No Actions
ORAL ORDER: As discussed at the Pretrial Conference, Wilmer, Hale and Richards, Layton & Finger shall make payable to the Clerk of the Court the amount of $3850. Ordered by Judge Colm F. Connolly on 8/11/2026. (mws)
2026-08-11
1
No Actions
MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices (Revised) - filed by Cytek Biosciences, Inc.. (Tigan, Jeremy) (Entered: 08/12/2026)
2026-08-12
1
SO ORDERED, re 430 MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices (Revised), filed by Cytek Biosciences, Inc. Signed by Judge Colm F. Connolly on 8/12/2026. (kmd) (Entered: 08/12/2026)
2026-08-12
1
Proposed Voir Dire by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 08/12/2026)
2026-08-12
1
Proposed Jury Instructions by Beckman Coulter, Inc. [Joint Proposed Preliminary Jury Instructions (Phase 1)]. (Cottrell, Frederick) (Entered: 08/12/2026)
2026-08-12
1
Oral Order
2026-08-12
1
No Actions
Remark
2026-08-12
1
No Actions
ORAL ORDER. The 429 MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices, filed by Cytek Biosciences, Inc., is DENIED. Signed by Judge Colm F. Connolly on 8/12/2026. (kmd)
2026-08-12
1
No Actions
Remark, re 8/11/2026 Oral Order: $3850 payment received. Receipt number 5887. (mws)
2026-08-12
1
No Actions
Letter to The Honorable Colm F. Connolly from Cytek Biosciences, Inc. regarding Scope of Evidence. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 08/13/2026)
2026-08-13
1
Letter to The Honorable Colm F. Connolly from Cytek Biosciences, Inc. regarding Scope of Evidence. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 08/13/2026)
2026-08-13
2
MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Haynes, Christine) (Entered: 08/13/2026)
2026-08-13
1
MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Haynes, Christine) (Entered: 08/13/2026)
2026-08-13
2
Letter to The Honorable Colm F. Connolly from Christine D. Haynes regarding response to Cytek's letter - re 434 Letter. (Haynes, Christine) (Entered: 08/13/2026)
2026-08-13
1
Letter to Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Cyteks August 13, 2026 Letter. (Attachments: # 1 Exhibit A)(Cottrell, Frederick) (Entered: 08/13/2026)
2026-08-13
1
Letter to Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Cyteks August 13, 2026 Letter. (Attachments: # 1 Exhibit A)(Cottrell, Frederick) (Entered: 08/13/2026)
2026-08-13
2
Official Transcript of Teleconference held on 8/14/2026 before Judge Colm F. Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/4/2026. Redacted Transcript Deadline set for 9/14/2026. Release of Transcript Restriction set for 11/12/2026. (mws) (Entered: 08/14/2026)
2026-08-14
1
SO ORDERED (as modified), re 435 MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 8/14/2026. (mws) (Entered: 08/14/2026)
2026-08-14
1
NOTICE requesting Clerk to remove Akkad Y. Moussa as co-counsel.. (Haynes, Christine) (Entered: 08/14/2026)
2026-08-14
1
MOTION for Pro Hac Vice Appearance of Attorney Khalil Waddell - filed by Beckman Coulter, Inc.. (Farnan, Kelly) (Entered: 08/14/2026)
2026-08-14
1
Pro Hac Vice Fee - Credit Card Payment received for Khalil Waddell. ( re 441 MOTION for Pro Hac Vice Appearance of Attorney Khalil Waddell )( Payment of $ 50, receipt number ADEDC-5043002).(Farnan, Kelly) (Entered: 08/14/2026)
2026-08-14
1
Telephone Conference
2026-08-14
1
No Actions
Oral Order AND Order Setting Teleconference
2026-08-14
1
No Actions
SO ORDERED
2026-08-14
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2026-08-14
1
No Actions
ORAL ORDER Setting Teleconference: A Telephone Conference is set for 8/14/2026 at 09:00 AM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 8/14/2026. (mws)
2026-08-14
1
No Actions
Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 8/14/2026. (Court Reporter Bonnie Archer). (mws)
2026-08-14
1
No Actions
MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Monasterio, Gabriela) (Entered: 08/16/2026)
2026-08-16
1
MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order)(Monasterio, Gabriela) (Entered: 08/16/2026)
2026-08-16
2
ORDER granting 443 MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices. Signed by Judge Colm F. Connolly on 8/17/2026. (kmd) (Entered: 08/17/2026)
2026-08-17
1
VERDICT SHEET by Beckman Coulter, Inc. [Proposed] Verdict Form (Phase I & II). (Cottrell, Frederick) (Entered: 08/17/2026)
2026-08-17
1
VERDICT SHEET by Cytek Biosciences, Inc. (Cytek's Proposed Phase I and Phase II Verdict Forms). (Clark, Cameron) (Entered: 08/17/2026)
2026-08-17
1
Preliminary Jury Instructions (Phase I). (Read in Open Court.) (kmd) (Entered: 08/18/2026)
2026-08-17
1
SO ORDERED
2026-08-17
1
No Actions
SO ORDERED, re 441 MOTION for Pro Hac Vice Appearance of Attorney Khalil Waddell, filed by Beckman Coulter, Inc. Ordered by Judge Colm F. Connolly on 8/17/2026. (kmd)
2026-08-17
1
No Actions
Add Attorneys - PHV only
2026-08-17
1
No Actions
Pro Hac Vice Attorney Khalil Waddell for Beckman Coulter, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)
2026-08-17
1
No Actions
Minute Entry for proceedings held before Judge Colm F. Connolly - Jury Trial held on 8/17/2026. (DAY 1.) (Court Reporter B. Archer.) (kmd)
2026-08-17
1
No Actions
Proposed Jury Instructions by Beckman Coulter, Inc. Joint [Proposed] Final Jury Instructions (Phase I). (Monasterio, Gabriela) (Entered: 08/18/2026)
2026-08-18
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint [Proposed] Final Jury Instructions (Phase II). (Monasterio, Gabriela) (Entered: 08/18/2026)
2026-08-18
1
VERDICT SHEET by Cytek Biosciences, Inc. - Cytek's [Proposed] Verdict Form (Phase 1). (Clark, Cameron) (Entered: 08/18/2026)
2026-08-18
1
Jury Trial - Begun
2026-08-18
1
No Actions
Minute Entry for proceedings held before Judge Colm F. Connolly - Jury Trial held on 8/18/2026. (DAY 2.) (Court Reporter Bonnie Archer.) (mws)
2026-08-18
1
No Actions
VERDICT SHEET by Beckman Coulter, Inc. Joint [Proposed] Verdict Form Instructions (Phase I). (Haynes, Christine) (Entered: 08/19/2026)
2026-08-19
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint [Proposed] Final Jury Instructions (Phase I). (Haynes, Christine) (Entered: 08/19/2026)
2026-08-19
1
STIPULATION and [Proposed] Order - filed by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 08/19/2026)
2026-08-19
1
Jury Trial - Held
2026-08-19
1
No Actions
Minute Entry for proceedings held before Judge Colm F. Connolly - Jury Trial held on 8/19/2026. (DAY 3.) (Court Reporter Bonnie Archer.) (mws)
2026-08-19
1
No Actions
Final Jury Instructions (Phase I). (Read in Open Court.) (kmd) (Main Document 454 replaced on 8/20/2026) (kmd). (Entered: 08/20/2026)
2026-08-20
1
SO ORDERED, re 453 STIPULATION - filed by Beckman Coulter, Inc. Signed by Judge Colm F. Connolly on 8/20/2026. (mws) (Entered: 08/20/2026)
2026-08-20
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint [Proposed] Preliminary Jury Instructions (Phase II). (Cottrell, Frederick) (Entered: 08/20/2026)
2026-08-20
1
[SEALED] Jury Notes (Phase I). (kmd) (Entered: 08/21/2026)
2026-08-20
1
[SEALED] JURY VERDICT (Phase I). (kmd) (Entered: 08/21/2026)
2026-08-20
1
REDACTED VERSION of 458 Jury Verdict (Phase I). (kmd) (Entered: 08/21/2026)
2026-08-20
1
Admitted Exhibit List (Phase I). (kmd) (Entered: 08/21/2026)
2026-08-20
1
Jury Trial - Held
2026-08-20
1
No Actions
Minute Entry for proceedings held before Judge Colm F. Connolly - Jury Trial held on 8/20/2026. (DAY 4.) (Court Reporter Bonnie Archer.) (mws)
2026-08-20
1
No Actions
Preliminary Jury Instructions (Phase II). (Read in Open Court.) (kmd) (Entered: 08/21/2026)
2026-08-21
1
Proposed Jury Instructions by Beckman Coulter, Inc. Joint [Proposed] Final Jury Instructions (Phase II). (Haynes, Christine) (Entered: 08/21/2026)
2026-08-21
1
VERDICT SHEET by Beckman Coulter, Inc. Joint [Proposed] Verdict Form (Phase II). (Haynes, Christine) (Entered: 08/21/2026)
2026-08-21
1
Final Jury Instructions (Phase II). (Read in Open Court.) (kmd) (Entered: 08/21/2026)
2026-08-21
1
[SEALED] JURY VERDICT (Phase II). (mws) (Entered: 08/21/2026)
2026-08-21
1
REDACTED VERSION of 465 Jury Verdict (Phase II). (mws) (Entered: 08/21/2026)
2026-08-21
1
Admitted Exhibit List (Phase II). (kmd) (Entered: 08/21/2026)
2026-08-21
1
[SEALED] Jury List. (kmd) (Entered: 08/21/2026)
2026-08-21
1
Jury Trial - Held
2026-08-21
1
No Actions
Jury Trial - Completed
2026-08-21
1
No Actions
Minute Entry for proceedings held before Judge Colm F. Connolly - Jury Trial completed on 8/21/2026. (DAY 5). (Court Reporter Bonnie Archer.) (mws)
2026-08-21
1
No Actions
Letter to The Honorable Colm F. Connolly from Karen Jacobs regarding Ex Parte Reexamination. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 08/25/2026)
2026-08-25
1
Letter to The Honorable Colm F. Connolly from Karen Jacobs regarding Ex Parte Reexamination. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 08/25/2026)
2026-08-25
2
Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding response to Cytek's letter re: ex parte reexamination - re 469 Letter. (Cottrell, Frederick) (Entered: 08/26/2026)
2026-08-26
1
Letter to The Honorable Colm F. Connolly from Karen Jacobs regarding Ex Parte Reexamination ('443 Patent). (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 08/31/2026)
2026-08-31
1
Letter to The Honorable Colm F. Connolly from Karen Jacobs regarding Ex Parte Reexamination ('443 Patent). (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 08/31/2026)
2026-08-31
2
ORAL ORDER: On or before September 14, 2026, the parties shall jointly submit a form of order to enter judgment on the verdict. At the same time, the parties shall submit a joint status report, indicating among other things how the case should proceed and listing any post-trial motions each party intends to file. Ordered by Judge Colm F. Connolly on 8/31/2026. (mws)
2026-08-31
1
No Actions
Oral Order AND Status Report Order
2026-08-31
1
No Actions
Joint STATUS REPORT by Beckman Coulter, Inc.. (Attachments: # 1 Text of Proposed Order Regarding Post-Trial Briefing)(Cottrell, Frederick) (Entered: 09/14/2026)
2026-09-14
1
PROPOSED ORDER [Proposed] Non-Final Judgment After Jury Verdict by Beckman Coulter, Inc.. (Cottrell, Frederick) (Entered: 09/14/2026)
2026-09-14
1
NON-FINAL JUDGMENT AFTER JURY VERDICT. Signed by Judge Colm F. Connolly on 9/15/2026. (mws) (Entered: 09/15/2026)
2026-09-15
1
ORDER Regarding Post-Trial Briefing, re 472 Status Report. Set Briefing Schedule: (Opening Brief due 10/13/2026; Answering Brief due 12/4/2026; Reply Brief due 1/8/2027). Signed by Judge Colm F. Connolly on 9/15/2026. (mws) (Entered: 09/15/2026)
2026-09-15
1
Judgment as a Matter of Law
2026-10-13
1
Text of Proposed Order
2026-10-13
2
Miscellaneous Relief
2026-10-13
1
Text of Proposed Order
2026-10-13
2
Brief - Opening Brief in Support
2026-10-13
1
Certificate of Compliance
2026-10-13
2
Judgment as a Matter of Law
2026-10-13
1
Brief - Opening Brief in Support
2026-10-13
1
Brief - Opening Brief in Support
2026-10-13
1
Declaration
2026-10-13
1